<html class="gs_el_sm gs_pfcs"><head><title>‪Andrew Lloyd‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.com/citations?user=AO9ywNcAAAAJ&amp;hl=en"><meta name="description" content="‪Professor of Biomedical Materials‬ - ‪‪Cited by 6,472‬‬ - ‪biomedical materials‬ - ‪drug delivery‬ - ‪contact lens technology‬"><meta property="og:description" content="‪Professor of Biomedical Materials‬ - ‪‪Cited by 6,472‬‬ - ‪biomedical materials‬ - ‪drug delivery‬ - ‪contact lens technology‬"><meta property="og:title" content="Andrew Lloyd"><meta property="og:image" content="https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=AO9ywNcAAAAJ&amp;citpid=2"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"c5E8YePkBInwmgGHsJCwCQ"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=AO9ywNcAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=AO9ywNcAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=AO9ywNcAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=AO9ywNcAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT3i8-kwCEBx40NuASpyYJzcufC6ahhJ"><input type="hidden" name="user" value="AO9ywNcAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">6472</td><td class="gsc_rsb_std">2044</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">40</td><td class="gsc_rsb_std">23</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">107</td><td class="gsc_rsb_std">58</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:866px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:824px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">460</div><div class="gsc_g_xtl" style="top:73px;">230</div><div class="gsc_g_xtl" style="top:113px;">115</div><div class="gsc_g_xtl" style="top:33px;">345</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:155px;height:5px;z-index:25"><span class="gsc_g_al">17</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:149px;height:11px;z-index:24"><span class="gsc_g_al">33</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:149px;height:11px;z-index:23"><span class="gsc_g_al">34</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:140px;height:20px;z-index:22"><span class="gsc_g_al">60</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:143px;height:17px;z-index:21"><span class="gsc_g_al">51</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:125px;height:35px;z-index:20"><span class="gsc_g_al">102</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:135px;height:25px;z-index:19"><span class="gsc_g_al">74</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:110px;height:50px;z-index:18"><span class="gsc_g_al">146</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:93px;height:67px;z-index:17"><span class="gsc_g_al">194</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:80px;height:80px;z-index:16"><span class="gsc_g_al">231</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:72px;height:88px;z-index:15"><span class="gsc_g_al">254</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:54px;height:106px;z-index:14"><span class="gsc_g_al">307</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:39px;height:121px;z-index:13"><span class="gsc_g_al">349</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:34px;height:126px;z-index:12"><span class="gsc_g_al">364</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:18px;height:142px;z-index:11"><span class="gsc_g_al">409</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:2px;height:158px;z-index:10"><span class="gsc_g_al">455</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:15px;height:145px;z-index:9"><span class="gsc_g_al">417</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:21px;height:139px;z-index:8"><span class="gsc_g_al">400</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:15px;height:145px;z-index:7"><span class="gsc_g_al">417</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:2px;height:158px;z-index:6"><span class="gsc_g_al">456</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:30px;height:130px;z-index:5"><span class="gsc_g_al">376</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:40px;height:120px;z-index:4"><span class="gsc_g_al">347</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:49px;height:111px;z-index:3"><span class="gsc_g_al">320</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:45px;height:115px;z-index:2"><span class="gsc_g_al">331</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:86px;height:74px;z-index:1"><span class="gsc_g_al">213</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=AO9ywNcAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3dAO9ywNcAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>4 articles</span></div><div class="gsc_rsb_m_na"><div class="gs_gray">0 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:0%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span class="gs_gray">not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:85px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:53pt;height:80pt;}}</style><img alt="Andrew Lloyd" sizes="print 53px,85px" src="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=AO9ywNcAAAAJ&amp;citpid=2" id="gsc_prf_pup-img" srcset="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=AO9ywNcAAAAJ&amp;citpid=2 85w,https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=AO9ywNcAAAAJ&amp;citpid=2 170w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Andrew Lloyd</div><div class="gsc_prf_il">Professor of Biomedical Materials</div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at brighton.ac.uk - <a href="http://www.brighton.ac.uk/scieng/contact/details.php?uid=awl1" rel="nofollow" class="gsc_prf_ila">Homepage</a></div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:biomedical_materials" class="gsc_prf_inta gs_ibl">biomedical materials</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:drug_delivery" class="gsc_prf_inta gs_ibl">drug delivery</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:contact_lens_technology" class="gsc_prf_inta gs_ibl">contact lens technology</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=AO9ywNcAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT3i8-kwCEBx40NuASpyYJzcufC6ahhJ"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=AO9ywNcAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=AO9ywNcAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=AO9ywNcAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=AO9ywNcAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=AO9ywNcAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:u5HHmVD_uO8C" class="gsc_a_at">DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization</a><div class="gs_gray">AL Lewis, MV Gonzalez, AW Lloyd, B Hall, Y Tang, SL Willis, SW Leppard, ...</div><div class="gs_gray">Journal of vascular and interventional radiology 17 (2), 335-342<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6043926685096509139" class="gsc_a_ac gs_ibl">444</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:d1gkVwhDpl0C" class="gsc_a_at">Ocular biomaterials and implants</a><div class="gs_gray">AW Lloyd, RGA Faragher, SP Denyer</div><div class="gs_gray">Biomaterials 22 (8), 769-785<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15358095207726861059" class="gsc_a_ac gs_ibl">310</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: A review</a><div class="gs_gray">L Xinming, C Yingde, AW Lloyd, SV Mikhalovsky, SR Sandeman, ...</div><div class="gs_gray">Contact Lens and Anterior Eye 31 (2), 57-64<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17181682865286387965" class="gsc_a_ac gs_ibl">300</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Drug delivery and targeting: for pharmacists and pharmaceutical scientists</a><div class="gs_gray">AM Hillery, AW Lloyd, J Swarbrick</div><div class="gs_gray">Crc press<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11194414178708508254" class="gsc_a_ac gs_ibl">261</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:u-x6o8ySG0sC" class="gsc_a_at">Well-defined biocompatible block copolymers via atom transfer radical polymerization of 2-methacryloyloxyethyl phosphorylcholine in protic media</a><div class="gs_gray">Y Ma, Y Tang, NC Billingham, SP Armes, AL Lewis, AW Lloyd, JP Salvage</div><div class="gs_gray">Macromolecules 36 (10), 3475-3484<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13578841533137512754" class="gsc_a_ac gs_ibl">250</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:9yKSN-GCB0IC" class="gsc_a_at">Glaucoma drainage devices; past, present, and future</a><div class="gs_gray">KS Lim, BDS Allan, AW Lloyd, A Muir, PT Khaw, KS Lim, BDS Allan, ...</div><div class="gs_gray">British journal of ophthalmology 82 (9), 1083-1089<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3401351129026714424" class="gsc_a_ac gs_ibl">225</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:Y0pCki6q_DkC" class="gsc_a_at">Doxorubicin eluting beads− 1: Effects of drug loading on bead characteristics and drug distribution</a><div class="gs_gray">AL Lewis, MV Gonzalez, SW Leppard, JE Brown, PW Stratford, GJ Phillips, ...</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 18 (9), 1691-1699<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5198742067012960853" class="gsc_a_ac gs_ibl">207</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:2osOgNQ5qMEC" class="gsc_a_at">Synthesis of biocompatible polymers. 1. Homopolymerization of 2-methacryloyloxyethyl phosphorylcholine via ATRP in protic solvents: an optimization study</a><div class="gs_gray">IY Ma, EJ Lobb, NC Billingham, SP Armes, AL Lewis, AW Lloyd, ...</div><div class="gs_gray">Macromolecules 35 (25), 9306-9314<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6756108906145674834" class="gsc_a_ac gs_ibl">191</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">The biocompatibility of crosslinkable copolymer coatings containing sulfobetaines and phosphobetaines</a><div class="gs_gray">SL West, JP Salvage, EJ Lobb, SP Armes, NC Billingham, AL Lewis, ...</div><div class="gs_gray">Biomaterials 25 (7-8), 1195-1204<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17992485525610557006" class="gsc_a_ac gs_ibl">176</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:qjMakFHDy7sC" class="gsc_a_at">Synthesis and characterization of biocompatible thermo-responsive gelators based on ABA triblock copolymers</a><div class="gs_gray">C Li, Y Tang, SP Armes, CJ Morris, SF Rose, AW Lloyd, AL Lewis</div><div class="gs_gray">Biomacromolecules 6 (2), 994-999<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13785403772605348387" class="gsc_a_ac gs_ibl">174</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Mesoporous carbide-derived carbon with porosity tuned for efficient adsorption of cytokines</a><div class="gs_gray">G Yushin, EN Hoffman, MW Barsoum, Y Gogotsi, CA Howell, ...</div><div class="gs_gray">Biomaterials 27 (34), 5755-5762<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6140801792676691152" class="gsc_a_ac gs_ibl">156</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:W7OEmFMy1HYC" class="gsc_a_at">Investigations into the azo reducing activity of a common colonic microorganism</a><div class="gs_gray">JL Bragger, AW Lloyd, SH Soozandehfar, SF Bloomfield, C Marriott, ...</div><div class="gs_gray">International journal of pharmaceutics 157 (1), 61-71<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16160978567657439701" class="gsc_a_ac gs_ibl">144</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Developments in microarray technologies</a><div class="gs_gray">DN Howbrook, AM van der Valk, MC O'Shaughnessy, DK Sarker, ...</div><div class="gs_gray">Drug discovery today 8 (14), 642-651<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14508044058901141451" class="gsc_a_ac gs_ibl">138</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:_FxGoFyzp5QC" class="gsc_a_at">Doxorubicin eluting beads—2: methods for evaluating drug elution and in-vitro: in-vivo correlation</a><div class="gs_gray">MV Gonzalez, Y Tang, GJ Phillips, AW Lloyd, B Hall, PW Stratford, ...</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 19 (2), 767-775<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6275563200717523982" class="gsc_a_ac gs_ibl">134</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:ufrVoPGSRksC" class="gsc_a_at">The osteo-odonto-keratoprosthesis (OOKP)</a><div class="gs_gray">C Liu, B Paul, R Tandon, E Lee, K Fong, I Mavrikakis, J Herold, S Thorp, ...</div><div class="gs_gray">Seminars in ophthalmology 20 (2), 113-128<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17550994891913210111" class="gsc_a_ac gs_ibl">134</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:YsMSGLbcyi4C" class="gsc_a_at">Well‐defined sulfobetaine‐based statistical copolymers as potential antibioadherent coatings</a><div class="gs_gray">AB Lowe, M Vamvakaki, MA Wassall, L Wong, NC Billingham, SP Armes, ...</div><div class="gs_gray">Journal of biomedical materials research 52 (1), 88-94<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11949702060114464221" class="gsc_a_ac gs_ibl">129</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Interfacial bioengineering to enhance surface biocompatibility.</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Medical device technology 13 (1), 18-21<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=211487667713535148" class="gsc_a_ac gs_ibl">123</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:WF5omc3nYNoC" class="gsc_a_at">Novel biocompatible phosphorylcholine-based self-assembled nanoparticles for drug delivery</a><div class="gs_gray">JP Salvage, SF Rose, GJ Phillips, GW Hanlon, AW Lloyd, IY Ma, ...</div><div class="gs_gray">Journal of controlled release 104 (2), 259-270<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5687685980723543677" class="gsc_a_ac gs_ibl">96</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Corneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgery</a><div class="gs_gray">H Eleftheriadis, M Cheong, S Sandeman, PP Syam, P Brittain, ...</div><div class="gs_gray">British Journal of Ophthalmology 86 (3), 299-305<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14723553014831072130" class="gsc_a_ac gs_ibl">95</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;citation_for_view=AO9ywNcAAAAJ:UebtZRa9Y70C" class="gsc_a_at">The effect of phosphorylcholine‐coated materials on the inflammatory response and fibrous capsule formation: <i>In vitro</i> and <i>in vivo</i> observations</a><div class="gs_gray">HH Goreish, AL Lewis, S Rose, AW Lloyd</div><div class="gs_gray">Journal of Biomedical Materials Research Part A: An Official Journal of The&nbsp;…<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5131362919542562514" class="gsc_a_ac gs_ibl">75</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:hqOjcs7Dif8C" class="gsc_a_at">Effects of plasma irradiation on the wettability and dissolution of compacts of griseofulvin</a><div class="gs_gray">A Naseem, CJ Olliff, LG Martini, AW Lloyd</div><div class="gs_gray">International journal of pharmaceutics 269 (2), 443-450<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14987069104680882484" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:aqlVkmm33-oC" class="gsc_a_at">Characterisation of physico-mechanical properties and degradation potential of calcium alginate beads for use in embolisation</a><div class="gs_gray">REJ Forster, F Thürmer, C Wallrapp, AW Lloyd, W Macfarlane, GJ Phillips, ...</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 21 (7), 2243-2251<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15213835358888197921" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:Se3iqnhoufwC" class="gsc_a_at">Biological responses to cationically charged phosphorylcholine-based materials in vitro</a><div class="gs_gray">SF Rose, AL Lewis, GW Hanlon, AW Lloyd</div><div class="gs_gray">Biomaterials 25 (21), 5125-5135<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18340785700780407726" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:roLk4NBRz8UC" class="gsc_a_at">Different kinetics of senescence in human fibroblasts and peritoneal mesothelial cells</a><div class="gs_gray">E Thomas, E Al-Baker, S Dropcova, S Denyer, N Ostad, A Lloyd, IR Kill, ...</div><div class="gs_gray">Experimental cell research 236 (1), 355-358<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6615379453130003910" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:3fE2CSJIrl8C" class="gsc_a_at">Bacterial adhesion to bisphosphonate coated hydroxyapatite</a><div class="gs_gray">A Ganguli, C Steward, SL Butler, GJ Philips, ST Meikle, AW Lloyd, ...</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 16 (4), 283-287<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12362179135320101197" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:0EnyYjriUFMC" class="gsc_a_at">In vitro host response assessment of biomaterials for cardiovascular stent manufacture</a><div class="gs_gray">M Santin, L Mikhalovska, AW Lloyd, S Mikhalovsky, L Sigfrid, SP Denyer, ...</div><div class="gs_gray">Journal of materials science: materials in medicine 15 (4), 473-477<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2037123835212042607" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:5nxA0vEk-isC" class="gsc_a_at">Biological evaluation and drug delivery application of cationically modified phospholipid polymers</a><div class="gs_gray">RR Palmer, AL Lewis, LC Kirkwood, SF Rose, AW Lloyd, TA Vick, ...</div><div class="gs_gray">Biomaterials 25 (19), 4785-4796<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4829534905222537215" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:8k81kl-MbHgC" class="gsc_a_at">Controlled biological response on blends of a phosphorylcholine-based copolymer with poly (butyl methacrylate)</a><div class="gs_gray">SF Long, S Clarke, MC Davies, AL Lewis, GW Hanlon, AW Lloyd</div><div class="gs_gray">Biomaterials 24 (23), 4115-4121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=716052462927293960" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:kNdYIx-mwKoC" class="gsc_a_at">Structural characteristics of activated carbons and ibuprofen adsorption affected by bovine serum albumin</a><div class="gs_gray">M Melillo, VM Gun'ko, SR Tennison, LI Mikhalovska, GJ Phillips, ...</div><div class="gs_gray">Langmuir 20 (7), 2837-2851<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2151487413479283317" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Bacterial adhesion to phosphorylcholine-based polymers with varying cationic charge and the effect of heparin pre-adsorption</a><div class="gs_gray">SF Rose, S Okere, GW Hanlon, AW Lloyd, AL Lewis</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 16 (11), 1003-1015<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18390966337058321052" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:KlAtU1dfN6UC" class="gsc_a_at">A comparison of the use of an ATP-based bioluminescent assay and image analysis for the assessment of bacterial adhesion to standard HEMA and biomimetic soft contact lenses</a><div class="gs_gray">CS Andrews, SP Denyer, B Hall, GW Hanlon, AW Lloyd</div><div class="gs_gray">Biomaterials 22 (24), 3225-3233<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3174485705105741807" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:TQgYirikUcIC" class="gsc_a_at">Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer</a><div class="gs_gray">REJ Forster, SA Small, Y Tang, CL Heaysman, AW Lloyd, W Macfarlane, ...</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 21 (9), 2683-2690<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5848036793773735147" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:r_AWSJRzSzQC" class="gsc_a_at">Drug Delivery Systems</a><div class="gs_gray">K Ashrafi, AL Lewis, C Heaysman, A Lloyd, G Philips</div><div class="gs_gray">US Patent App. 13/981,706<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7102887153942168365" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Inflammatory cytokine removal by an activated carbon device in a flowing system</a><div class="gs_gray">SR Sandeman, CA Howell, SV Mikhalovsky, GJ Phillips, AW Lloyd, ...</div><div class="gs_gray">Biomaterials 29 (11), 1638-1644<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3554157450534112261" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:k_IJM867U9cC" class="gsc_a_at">Drug carriers comprising amphiphilic block copolymers</a><div class="gs_gray">A Lewis, S Armes, A Lloyd, J Salvage</div><div class="gs_gray">US Patent App. 10/506,805<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7018302197050367322" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">Fibrinogen adsorption and platelet adhesion to metal and carbon coatings</a><div class="gs_gray">LI Mikhalovska, M Santin, SP Denyer, AW Lloyd, DG Teer, S Field, ...</div><div class="gs_gray">Thrombosis and haemostasis 92 (11), 1032-1039<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2970029462014243246" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:ZeXyd9-uunAC" class="gsc_a_at">The in vitro adsorption of cytokines by polymer-pyrolysed carbon</a><div class="gs_gray">CA Howell, SR Sandeman, GJ Phillips, AW Lloyd, JG Davies, ...</div><div class="gs_gray">Biomaterials 27 (30), 5286-5291<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14999813937991191002" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:M3ejUd6NZC8C" class="gsc_a_at">Serum protein absorption on silk fibroin fibers and films: Surface opsonization and binding strength</a><div class="gs_gray">A Motta, C Migliaresi, AW Lloyd, SP Denyer, M Santin</div><div class="gs_gray">Journal of bioactive and compatible polymers 17 (1), 23-35<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11415928411366237397" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:HDshCWvjkbEC" class="gsc_a_at">Decaying Raphia farinifera palm trees provide a source of sodium for wild chimpanzees in the Budongo Forest, Uganda</a><div class="gs_gray">V Reynolds, AW Lloyd, F Babweteera, CJ English</div><div class="gs_gray">PloS one 4 (7), e6194<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16841421774148362032" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:Zph67rFs4hoC" class="gsc_a_at">Calcium-binding phospholipids as a coating material for implant osteointegration</a><div class="gs_gray">M Santin, W Rhys-Williams, J O'Reilly, MC Davies, K Shakesheff, ...</div><div class="gs_gray">Journal of the Royal Society Interface 3 (7), 277-281<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13424587085090942152" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:maZDTaKrznsC" class="gsc_a_at">Microstructure changes of polyurethane by inclusion of chemically modified carbon nanotubes at low filler contents</a><div class="gs_gray">LV Karabanova, RLD Whitby, A Korobeinyk, O Bondaruk, JP Salvage, ...</div><div class="gs_gray">Composites Science and Technology 72 (8), 865-872<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1979466816000504867" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">Towards a synthetic osteo-odonto-keratoprosthesis</a><div class="gs_gray">R Viitala, V Franklin, D Green, C Liu, A Lloyd, B Tighe</div><div class="gs_gray">Acta biomaterialia 5 (1), 438-452<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17034267091972444933" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:IWHjjKOFINEC" class="gsc_a_at">Gradient semi-interpenetrating polymer networks based on polyurethane and poly (vinyl pyrrolidone)</a><div class="gs_gray">LV Karabanova, SV Mikhalovsky, AW Lloyd, G Boiteux, LM Sergeeva, ...</div><div class="gs_gray">Journal of Materials Chemistry 15 (4), 499-507<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=87924424329779684" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:DyXnQzXoVgIC" class="gsc_a_at">Antimycobacterial agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (10), 480-481<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17678359362366176049" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:4TOpqqG69KYC" class="gsc_a_at">Azopolymers: a means of colon specific drug delivery?</a><div class="gs_gray">AW Lloyd, GP Martin, SH Soozandehfar</div><div class="gs_gray">International journal of pharmaceutics 106 (3), 255-260<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6609820251349937839" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:dhFuZR0502QC" class="gsc_a_at">Assessing the in vitro biocompatibility of a novel carbon device for the treatment of sepsis</a><div class="gs_gray">SR Sandeman, CA Howell, GJ Phillips, AW Lloyd, JG Davies, ...</div><div class="gs_gray">Biomaterials 26 (34), 7124-7131<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2536808193252237764" class="gsc_a_ac gs_ibl">36</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:TFP_iSt0sucC" class="gsc_a_at">Polyurethane/poly (hydroxyethyl methacrylate) semi-interpenetrating polymer networks for biomedical applications</a><div class="gs_gray">LV Karabanova, AW Lloyd, SV Mikhalovsky, M Helias, GJ Phillips, ...</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 17 (12), 1283-1296<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7016156305950932907" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Human keratocyte migration into collagen gels declines with in vitro ageing</a><div class="gs_gray">SR Sandeman, MC Allen, C Liu, RGA Faragher, AW Lloyd</div><div class="gs_gray">Mechanisms of ageing and development 119 (3), 149-157<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2639028219949001920" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:qUcmZB5y_30C" class="gsc_a_at">Effects of phosphatidylserine coatings on titanium on inflammatory cells and cell-induced mineralisation in vitro</a><div class="gs_gray">M Bosetti, AW Lloyd, M Santin, SP Denyer, M Cannas</div><div class="gs_gray">Biomaterials 26 (36), 7572-7578<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9351586869468260940" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:4DMP91E08xMC" class="gsc_a_at">A Comparison of Glycine, Sarcosine, <i>N,N</i>‐Dimethylglycine, Glycinebetaine and <i>N</i>‐Modified Betaines as Liposome Cryoprotectants</a><div class="gs_gray">AW Lloyd, JA Baker, G Smith, CJ Olliff, KJ Rutt</div><div class="gs_gray">Journal of pharmacy and pharmacology 44 (6), 507-511<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16169535852465657268" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:R3hNpaxXUhUC" class="gsc_a_at">The in vitro corneal biocompatibility of hydroxyapatite coated carbon mesh</a><div class="gs_gray">SR Sandeman, H Jeffery, CA Howell, M Smith, SV Mikhalovsky, AW Lloyd</div><div class="gs_gray">Biomaterials 30 (18), 3143-3149<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8464104620549309196" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">The interactions of bisphosphonates in solution and as coatings on hydroxyapatite with osteoblasts</a><div class="gs_gray">A Ganguli, C Henderson, MH Grant, ST Meikle, AW Lloyd, I Goldie</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 13 (10), 923-931<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5200038132772138094" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">Cell behaviour on phospholipids-coated surfaces</a><div class="gs_gray">M Bosetti, M Santin, AW Lloyd, SP Denyer, M Sabbatini, M Cannas</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 18 (4), 611-617<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1760567827596111015" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:mVmsd5A6BfQC" class="gsc_a_at">Novel materials to enhance keratoprosthesis integration</a><div class="gs_gray">SR Sandeman, RGA Faragher, MCA Allen, C Liu, AW Lloyd</div><div class="gs_gray">British Journal of Ophthalmology 84 (6), 640-644<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9887414480608281399" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:_kc_bZDykSQC" class="gsc_a_at">The development of in vitro biocompatibility tests for the evaluation of intraocular biomaterials</a><div class="gs_gray">AW Lloyd, S Dropcova, RGA Faragher, PR Gard, GW Hanlon, ...</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 10 (10), 621-627<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11284441118400304155" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:QIV2ME_5wuYC" class="gsc_a_at">In vivo assessment of the osteointegrative potential of phosphatidylserine-based coatings</a><div class="gs_gray">A Merolli, M Bosetti, L Giannotta, AW Lloyd, SP Denyer, W Rhys-Williams, ...</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 17 (9), 789-794<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18345643175280893538" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:-f6ydRqryjwC" class="gsc_a_at">The effect of protein binding on ibuprofen adsorption to activated carbons</a><div class="gs_gray">M Melillo, GJ Phillips, JG Davies, AW Lloyd, SR Tennison, ...</div><div class="gs_gray">Carbon 42 (3), 565-571<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17882683787015062175" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:4JMBOYKVnBMC" class="gsc_a_at">Calcium phosphate sonoelectrodeposition on carbon fabrics and its effect on osteoblast cell viability in vitro</a><div class="gs_gray">H Han, SV Mikhalovsky, GJ Phillips, AW Lloyd</div><div class="gs_gray">New Carbon Materials 22 (2), 121-125<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10520301283094084921" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:hC7cP41nSMkC" class="gsc_a_at">A model for the preliminary biological screening of potential keratoprosthetic biomaterials</a><div class="gs_gray">SR Sandeman, AW Lloyd, BJ Tighe, V Franklin, J Li, F Lydon, CSC Liu, ...</div><div class="gs_gray">Biomaterials 24 (26), 4729-4739<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9568283022516631490" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:EUQCXRtRnyEC" class="gsc_a_at">The role of interfacial chemistry and interactions in the dynamics of thermosetting polyurethane–multiwalled carbon nanotube composites at low filler contents</a><div class="gs_gray">LV Karabanova, RLD Whitby, VA Bershtein, AV Korobeinyk, PN Yakushev, ...</div><div class="gs_gray">Colloid and Polymer Science 291 (3), 573-583<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16666536669026204308" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Enhancing learning and teaching quality-integration of networked learning technologies into undergraduate modules</a><div class="gs_gray">M Sosabowski, K Herson, A Lloyd</div><div class="gs_gray">Active Learning 8, 20-25<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7393252689401144598" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:KTwcwpFFj4wC" class="gsc_a_at">Preparation and characterisation of vandetanib-eluting radiopaque beads for locoregional treatment of hepatic malignancies</a><div class="gs_gray">A Hagan, GJ Phillips, WM Macfarlane, AW Lloyd, P Czuczman, AL Lewis</div><div class="gs_gray">European Journal of Pharmaceutical Sciences 101, 22-30<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10097560990665103730" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:fPk4N6BV_jEC" class="gsc_a_at">Gradient semi-interpenetrating polymer networks based on polyurethane and poly (2-hydroxyethyl methacrylate) for biomedical applications</a><div class="gs_gray">LV Karabanova, SV Mikhalovsky, AW Lloyd</div><div class="gs_gray">Journal of Materials Chemistry 22 (16), 7919-7928<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3628648536841467988" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:u9iWguZQMMsC" class="gsc_a_at">Mesoporous carbons</a><div class="gs_gray">Y Gogotsi, G Yushin, SV Mikhalovsky, AW Lloyd, GJ Phillips</div><div class="gs_gray">US Patent App. 12/096,526<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8524885846343483140" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:lSLTfruPkqcC" class="gsc_a_at">Phase separation in the polyurethane/poly (2‐hydroxyethyl methacrylate) semi‐interpenetrating polymer networks synthesized by different ways</a><div class="gs_gray">LV Karabanova, G Boiteux, G Seytre, I Stevenson, AW Lloyd, ...</div><div class="gs_gray">Polymer Engineering &amp; Science 48 (3), 588-597<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11038151092856554650" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:mB3voiENLucC" class="gsc_a_at">Implementation strategies for educational intranet resources</a><div class="gs_gray">K Herson, M Sosabowski, A Lloyd, S Flowers, C Paine, B Newton</div><div class="gs_gray">British Journal of Educational Technology 31 (1), 47-55<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10065247246163552778" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:L8Ckcad2t8MC" class="gsc_a_at">A standard strain of human ocular keratocytes</a><div class="gs_gray">S Dropcova, SP Denyer, AW Lloyd, PR Gard, GW Hanlon, ...</div><div class="gs_gray">Ophthalmic research 31 (1), 33-41<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=135951771221355048" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:35N4QoGY0k4C" class="gsc_a_at">The cytotoxicity of highly porous medical carbon adsorbents</a><div class="gs_gray">LM Barnes, GJ Phillips, JG Davies, AW Lloyd, E Cheek, SR Tennison, ...</div><div class="gs_gray">Carbon 47 (8), 1887-1895<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15779008323531846711" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:isC4tDSrTZIC" class="gsc_a_at">Indirect enantiomeric separation of 2-arylpropionic acids and structurally related compounds by reversed phase HPLC</a><div class="gs_gray">MJ Thomason, YF Hung, W Rhys-Williams, GW Hanlon, AW Lloyd</div><div class="gs_gray">Journal of pharmaceutical and biomedical analysis 15 (11), 1765-1774<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=757332999274802346" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:0sTkTiv_uMkC" class="gsc_a_at">Hypoxia as a target for drug combination therapy of liver cancer</a><div class="gs_gray">C Bowyer, AL Lewis, AW Lloyd, GJ Phillips, WM Macfarlane</div><div class="gs_gray">Anti-cancer drugs 28 (7), 771<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5499626667774448590,18326826465893796378" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:SAZ1SQo2q1kC" class="gsc_a_at">Mineral acquisition from clay by Budongo forest chimpanzees</a><div class="gs_gray">V Reynolds, AW Lloyd, CJ English, P Lyons, H Dodd, C Hobaiter, ...</div><div class="gs_gray">PLoS One 10 (7), e0134075<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6133733187062073252" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:r0BpntZqJG4C" class="gsc_a_at">Identifying and overcoming staff resistance to computer based learning and teaching methods-shedding millstones to achieve milestones</a><div class="gs_gray">M Sosabowski, K Herson, A Lloyd</div><div class="gs_gray">Active Learning 9, 26-31<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15908905228959823169" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:RHpTSmoSYBkC" class="gsc_a_at">A study of modified betaines as cryoprotective additives</a><div class="gs_gray">AW LLOYD, CJ OLLIFF, KENJ RUTT</div><div class="gs_gray">Journal of pharmacy and pharmacology 46 (9), 704-707<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17428449110952937343" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:abG-DnoFyZgC" class="gsc_a_at">Examining porous bio-active glass as a potential osteo-odonto-keratoprosthetic skirt material</a><div class="gs_gray">R Huhtinen, S Sandeman, S Rose, E Fok, C Howell, L Fröberg, N Moritz, ...</div><div class="gs_gray">Journal of materials science: Materials in medicine 24 (5), 1217-1227<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17492322577474235143" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:ldfaerwXgEUC" class="gsc_a_at">In vitro cytotoxicity assessment of carbon fabric coated with calcium phosphate</a><div class="gs_gray">H Han, GJ Phillips, SV Mikhalovsky, AW Lloyd</div><div class="gs_gray">New Carbon Materials 23 (2), 139-143<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2610141644238139261,1675392563263310489" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:BqipwSGYUEgC" class="gsc_a_at">Sonoelectrochemical deposition of calcium phosphates on carbon materials: effect of current density</a><div class="gs_gray">HM Han, GJ Phillips, SV Mikhalovsky, S FitzGerald, AW Lloyd</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 19 (4), 1787-1791<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11549002741252562384" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:j3f4tGmQtD8C" class="gsc_a_at">Assessing the in vitro cell based ocular compatibility of contact lens materials</a><div class="gs_gray">AW Lloyd, RGA Faragher, M Wassall, W Rhys-Williams, L Wong, ...</div><div class="gs_gray">Contact Lens and Anterior Eye 23 (4), 119-123<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10796979952946250962" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:hFOr9nPyWt4C" class="gsc_a_at">A mechanistic investigation into the microbial chiral inversion of 2-arylpropionic acids using deuterated derivatives of 2-phenylpropionic acid</a><div class="gs_gray">W Rhys-Williams, F McCarthy, J Baker, YF Hung, MJ Thomason, ...</div><div class="gs_gray">Enzyme and microbial technology 22 (4), 281-287<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=232730520265484096" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Development of a combination drug-eluting bead: towards enhanced efficacy for locoregional tumour therapies</a><div class="gs_gray">REJ Forster, Y Tang, C Bowyer, AW Lloyd, W Macfarlane, GJ Phillips, ...</div><div class="gs_gray">Anti-cancer drugs 23 (4), 355-369<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12372954010818492851" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:YFjsv_pBGBYC" class="gsc_a_at">Basic principles of liposomes for drug use</a><div class="gs_gray">GP Martin, AW Lloyd</div><div class="gs_gray">Liposome Dermatics, 20-26<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9336125474683750412" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:GnPB-g6toBAC" class="gsc_a_at">Domain-driven binding of fibrin (ogen) onto silk fibroin biomaterials</a><div class="gs_gray">M Santin, SP Denyer, AW Lloyd, A Motta</div><div class="gs_gray">Journal of bioactive and compatible polymers 17 (3), 195-208<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14648659063501138189" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Does MMP-2 expression and secretion change with increasing serial passage of keratocytes in culture?</a><div class="gs_gray">SR Sandeman, RGA Faragher, MCA Allen, C Liu, AW Lloyd</div><div class="gs_gray">Mechanisms of ageing and development 122 (2), 157-167<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6522313499316318029" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:iH-uZ7U-co4C" class="gsc_a_at">Intranet‐based learning: a one‐year study of student utilisation</a><div class="gs_gray">K Herson, MH Sosabowski, AW Lloyd</div><div class="gs_gray">Journal of Computer Assisted Learning 15 (4), 269-278<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18266277287823478858" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:hMod-77fHWUC" class="gsc_a_at">Implementation and student assessment of intranet-based learning resources</a><div class="gs_gray">MH Sosabowski, K Herson, AW Lloyd</div><div class="gs_gray">American Journal of Pharmaceutical Education 62 (3), 302-306<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8978329853146189110" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">Nanoprecipitation of polymeric nanoparticle micelles based on 2-methacryloyloxyethyl phosphorylcholine (MPC) with 2-(diisopropylamino) ethyl methacrylate (DPA), for&nbsp;…</a><div class="gs_gray">JP Salvage, C Thom, AL Lewis, GJ Phillips, AW Lloyd</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 26 (3), 1-14<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1594778267078949416" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">A comparison of carboxylate salts as liposomal cryoprotectants</a><div class="gs_gray">AW Lloyd, CJ Olliff, KJ Rutt</div><div class="gs_gray">International journal of pharmaceutics 131 (2), 257-262<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17719080461193505993" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:RYcK_YlVTxYC" class="gsc_a_at">Factors inducing in-stent restenosis: an in-vitro model.</a><div class="gs_gray">M Santin, C Morris, M Harrison, L Mikhalovska, AW Lloyd, S Mikhalovsky</div><div class="gs_gray">The Medical journal of Malaysia 59, 93-94<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14478577769889024286" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">Adsorption of inflammatory cytokines and endotoxin by mesoporous polymers and activated carbons</a><div class="gs_gray">MC Murphy, S Patel, GJ Phillips, JG Davies, AW Lloyd, VM Gun’ko, ...</div><div class="gs_gray">Studies in Surface Science and Catalysis 144, 515-520<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16880401142271163064" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:M3NEmzRMIkIC" class="gsc_a_at">Volume-activated chloride currents in HeLa cells are blocked by tamoxifen but not by a membrane impermeant quaternary analogue</a><div class="gs_gray">M Sahebgharani, SP Hardy, AW Lloyd, AC Hunter, MC Allen</div><div class="gs_gray">Cellular Physiology and Biochemistry 11 (2), 99-104<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3630581356009752965" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:ns9cj8rnVeAC" class="gsc_a_at">Membrane impermeant antioestrogens discriminate between ligand-and voltage-gated cation channels in NG108-15 cells</a><div class="gs_gray">MC Allen, PA Gale, AC Hunter, A Lloyd, SP Hardy</div><div class="gs_gray">Biochimica et Biophysica Acta (BBA)-Biomembranes 1509 (1-2), 229-236<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3655234671641426349" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:blknAaTinKkC" class="gsc_a_at">Evaluation of Information Technology Use Among First Year Pharmacy Students</a><div class="gs_gray">MH Sosabowski, K Herson, AW Lloyd, P Bell</div><div class="gs_gray">American Journal of Pharmaceutical Education 62 (4), 433-437<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17174313274243127799" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:O3NaXMp0MMsC" class="gsc_a_at">The stereo inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs and structurally related compounds by Verticillium lecanii</a><div class="gs_gray">MJ Thomason, W Rhys-Williams, AW Lloyd, GW Hanlon</div><div class="gs_gray">Journal of applied microbiology 85 (1), 155-163<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3260345012879780876" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:NMxIlDl6LWMC" class="gsc_a_at">Modifying the drug discovery/drug development paradigm</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">Drug Discovery Today 10 (2), 397-398<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9052226006921576008" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:BCdnXsLIVDwC" class="gsc_a_at">Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods</a><div class="gs_gray">A Hagan, M Caine, C Press, WM Macfarlane, G Phillips, AW Lloyd, ...</div><div class="gs_gray">European Journal of Pharmaceutical Sciences 136, 104943<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4306930369584209055" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:NaGl4SEjCO4C" class="gsc_a_at">Synthesis and bacterial degradation of an azopolymer</a><div class="gs_gray">SH Soozandehfar, JL Bragger, GP Martin, AW Lloyd</div><div class="gs_gray">International journal of pharmaceutics 198 (1), 71-82<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2051362238856787138" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:M05iB0D1s5AC" class="gsc_a_at">In vitro evaluation of novel biomimetic intraocular lens materials</a><div class="gs_gray">AW Lloyd, RW Bowers, S Dropcova, SP Denyer, RGA Faragher, PR Gard, ...</div><div class="gs_gray">Investigative Ophthalmology and Visual Science 38 (4), 884-884<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4210892684290101606" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:_xSYboBqXhAC" class="gsc_a_at">Chiral inversion of 2‐phenylpropionic acid by Cordyceps militaris</a><div class="gs_gray">YF Hung, MJ Thomason, W Rhys‐Williams, AW Lloyd, GW Hanlon</div><div class="gs_gray">Journal of applied bacteriology 81 (3), 242-250<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16231859705253886935" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:4e5Qn2KL_jwC" class="gsc_a_at">Synthesis of diacylglycerol analogues as potential second-messenger antagonists and inhibitors of protein kinase C</a><div class="gs_gray">JC Briggs, AH Haines, RJK Taylor, AP Dawson, I Gibson, J Hook, A Lloyd, ...</div><div class="gs_gray">Carbohydrate research 234, 23-35<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13985249761092001114" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:NMlhSUseqAsC" class="gsc_a_at">Synthesis and characterisation of cationic quaternary ammonium-modified polyvinyl alcohol hydrogel beads as a drug delivery embolisation system</a><div class="gs_gray">CL Heaysman, GJ Phillips, AW Lloyd, AL Lewis</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 27 (3), 1-10<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9357330909080833553" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=AO9ywNcAAAAJ:geHnlv5EZngC" class="gsc_a_at">Phospholipid-coated implants</a><div class="gs_gray">AW Lloyd, M Santin, SP Denyer, W Rhys-Williams, WG Love</div><div class="gs_gray">US Patent 6,863,693<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1384855498650643624" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:a0OBvERweLwC" class="gsc_a_at">Experimental flow studies in glaucoma drainage device development</a><div class="gs_gray">TA team</div><div class="gs_gray">British Journal of Ophthalmology 85 (10), 1231-1236<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4640050902690190534" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:70eg2SAEIzsC" class="gsc_a_at">A biocompatible coating for IOLs</a><div class="gs_gray">AW Lloyd, S Dropcova, SV Mikhalovsky, SP Denyer, PR Gard, ...</div><div class="gs_gray">Vision Research 36, 73-73<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=369988728378019547" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:JV2RwH3_ST0C" class="gsc_a_at">Extent of chiral inversion of the 2‐arylpropionic acids by <i>Cordyceps militaris</i></a><div class="gs_gray">W Rhys‐Williams, MJ Thomason, YF Hung, GW Hanlon, AW Lloyd</div><div class="gs_gray">Chirality 10 (6), 528-534<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12197615379565714265,6601887760741387944" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:3s1wT3WcHBgC" class="gsc_a_at">In vitro evaluation of a novel biocompatible intraocular lens coating</a><div class="gs_gray">GW Hanlon, RWJ Bowers, S Dropcova, SP Denyer, RG Faragher, ...</div><div class="gs_gray">Investigative Ophthalmology &amp; Visual Science 38 (4), 885-885<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9474718032645656332" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ZHo1McVdvXMC" class="gsc_a_at">In vivo evaluation of novel biomimetic intraocular lenses</a><div class="gs_gray">M Filipec, RWJ Bowers, S Dropcova, SP Denyer, RGA Faragher, PR Gard, ...</div><div class="gs_gray">Investigative Ophthalmology and Visual Science 38 (4), 883-883<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6086501841836916089" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:J_g5lzvAfSwC" class="gsc_a_at">A mechanistic investigation of the microbial chiral inversion of 2‐phenylpropionic acid by <i>Verticillium lecanii</i></a><div class="gs_gray">MJ Thomason, W Rhys‐Williams, YF Hung, JA Baker, GW Hanlon, ...</div><div class="gs_gray">Chirality 9 (3), 254-260<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6629513636183028378" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:HoB7MX3m0LUC" class="gsc_a_at">Azo reduction is mediated by enzymatically generated low molecular weight electron carriers</a><div class="gs_gray">AW Lloyd, NA Hodges, SH Soozandehfar, GP Martin</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 45 (2), 1107<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10359867781496957863" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Sonoelectrochemical deposition of calcium phosphate coatings on carbon materials—effect of electrolyte concentration</a><div class="gs_gray">HM Han, GJ Phillips, SV Mikhalovsky, S FitzGerald, AW Lloyd</div><div class="gs_gray">Journal of Materials Science: Materials in Medicine 19 (8), 2845-2850<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1542183848011784825" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:SeFeTyx0c_EC" class="gsc_a_at">Bacterial cellulose scaffolds for cartilage repair: Tissue engineering</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">Materials Today 7 (11), 28<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15885477529064731921" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:vV6vV6tmYwMC" class="gsc_a_at">Monitor: molecules and profiles</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug discovery today 2 (10), 445-448<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15215263378984886768,5210267069050069838,1643066768435953973" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Methods to quantify the biotin-binding capacity of streptavidin-coated polypropylene PCR plates</a><div class="gs_gray">AM van der Valk, DN Howbrook, MC O'shaughnessy, DK Sarker, ...</div><div class="gs_gray">Biotechnology letters 25 (16), 1325-1328<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8057205710441716694" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:u_35RYKgDlwC" class="gsc_a_at">Opacification of SC60B-OUV lens implant following routine phacoemulsification surgery: case report and EM study</a><div class="gs_gray">A Moosavi, P Fox, M Harrison, GJ Phillips, AW Lloyd</div><div class="gs_gray">British journal of ophthalmology 87 (6), 800-801<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14641662919623320669" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:RGFaLdJalmkC" class="gsc_a_at">Demonstration of the Chiral Inversion of 2‐Phenylpropionic Acid by Cell Extracts from <i>Verticillium lecanii</i></a><div class="gs_gray">W Rhys‐Williams, MJ Thomason, AW Lloyd, GW Hanlon</div><div class="gs_gray">Pharmacy and Pharmacology Communications 2 (11), 537-540<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6645920468556063733" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:rO6llkc54NcC" class="gsc_a_at">Bidirectional chiral inversion of 2-phenylpropionic acid enantiomers in non-growing cultures of Verticillium Lecanii</a><div class="gs_gray">MJ Thomason, W Rhys-Williams, GW Hanlon, AW Lloyd, AJ Hutt</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 47 (12), 1059<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12249766282573172448" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:VL0QpB8kHFEC" class="gsc_a_at">Adaptation by Budongo Forest chimpanzees (Pan troglodytes schweinfurthii) to loss of a primary source of dietary sodium</a><div class="gs_gray">V Reynolds, A Lloyd, C English</div><div class="gs_gray">Afr. Primates 7, 156-162<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=698643852069927902" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:D03iK_w7-QYC" class="gsc_a_at">Hurdles to successful implementation of “Learning Trees”</a><div class="gs_gray">MH Sosabowski, K Herson, AW Lloyd</div><div class="gs_gray">British Journal of Educational Technology 30 (1), 61-64<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5095838569732684087" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:NhqRSupF_l8C" class="gsc_a_at">The evaluation of N-modified betaines as erythrocyte cryoprotectants</a><div class="gs_gray">AW Lloyd, JA Baker, CJ Olliff, KJ Rutt</div><div class="gs_gray">Cryo-Letters 13 (5), 337-348<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17775016005476809298" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:vRqMK49ujn8C" class="gsc_a_at">Novel biocompatible block copolymers for drug delivery</a><div class="gs_gray">JP Salvage, GW Hanlon, GJ Phillips, SL West, AW Lloyd</div><div class="gs_gray">Journal of controlled release 87 (1-3), 230-233<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14278062884796714553" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">Stereochemistry: handling interactions</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 4 (2), 127<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8622288397235712064" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:dfsIfKJdRG4C" class="gsc_a_at">Demonstration of the chiral inversion of ibuprofen by Verticillium lecanii in non‐growing cultures</a><div class="gs_gray">MJ Thomason, W Rhys‐Williams, AJ Hutt, AW Lloyd, GW Hanlon</div><div class="gs_gray">Letters in applied microbiology 23 (6), 417-420<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16521612382911680854" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:bFI3QPDXJZMC" class="gsc_a_at">The effects of adsorbed phosphorylcholine based biomimetic copolymers on bacterial adhesion to poly (methylmethacrylate) intraocular lens materials</a><div class="gs_gray">S Dropcova, RWJ Bowers, SP Denyer, RGA Faragher, PR Gard, B Hall, ...</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 47 (12), 1063-1063<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15064690347266763147" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:KqnX2w3egDsC" class="gsc_a_at">Possible mineral contributions to the diet and health of wild chimpanzees in three East African forests</a><div class="gs_gray">V Reynolds, A Pascual‐Garrido, AW Lloyd, P Lyons, C Hobaiter</div><div class="gs_gray">American journal of primatology 81 (6), e22978<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6937907192168265811" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">声电化学法在炭织物表面制备的磷酸钙涂层及其对成骨细胞活性的影响</a><div class="gs_gray">韩红梅</div><div class="gs_gray">新型炭材料 22 (2), 121-125<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18243511606533970596" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Applications of radio frequency cold plasma treatment of polypropylene PCR plates</a><div class="gs_gray">D Howbrook, D Sarker, A Lloyd, A Louwrier</div><div class="gs_gray">Biotechnology letters 24 (24), 2071-2074<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14549878781271715409" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:f2IySw72cVMC" class="gsc_a_at">Novel base materials for intraocular lenses</a><div class="gs_gray">RGA Faragher, SP Denyer, S Dropoova, PR Gard, B Hall, GW Hanlon, ...</div><div class="gs_gray">European Journal of Pharmaceutical Sciences, S175<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13096075382265545072" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:CHSYGLWDkRkC" class="gsc_a_at">In-vitro evaluation of novel biomimetic hydrogels: potential new base materials for intraocular lenses</a><div class="gs_gray">RGA Faragher, RWJ Bowers, SP Denyer, S Dropcova, PR Gard, B Hall, ...</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 47 (12), 1068<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4835341677146841406" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:QaSi33NTfwYC" class="gsc_a_at">General practitioners and pharmacists interprofessional communication.</a><div class="gs_gray">D Ruth, V Constable, J Daffey, D Dammery, MM Hodge, C Hogan, ...</div><div class="gs_gray">Australian family physician 23 (8), 1544-1546<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10068403428799788590" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Chiral inversion of 2-phenylpropionic acid in non-growing cultures of Verticillium lecanii</a><div class="gs_gray">MJ Thomason, GW Hanlon, AW Lloyd, AJ Hutt</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 46 (2), 1047-1047<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17072900008460116276" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:natZJ_-F0IUC" class="gsc_a_at">Unusual behaviour induced by phase separation in hydrogel microspheres</a><div class="gs_gray">CL Heaysman, GJ Philips, AW Lloyd, AL Lewis</div><div class="gs_gray">Acta biomaterialia 53, 190-198<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18182784768995955679" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:L_l9e5I586QC" class="gsc_a_at">3D Artificial Nanodiamonds Containing Nanocomposites Based on Hybrid Polyurethane-Poly (2-Hydroxyethyl Methacrylate) Polymer Matrix</a><div class="gs_gray">LV Karabanova, AW Lloyd, SV Mikhalovsky</div><div class="gs_gray">Nanoplasmonics, Nano-Optics, Nanocomposites, and Surface Studies, 149-164<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3899900131590254765" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:bnK-pcrLprsC" class="gsc_a_at">Biomedical applications of biomimetic polymers: the phosphorylcholine-containing polymers</a><div class="gs_gray">AL Lewis, AW Lloyd</div><div class="gs_gray">Biomimetic, Bioresponsive, and Bioactive Materials: An Introduction to&nbsp;…<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14926870550174780527" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:8VtEwCQfWZkC" class="gsc_a_at">Assessment of interprofessional competencies for health professional students in fieldwork education placements</a><div class="gs_gray">M Brewer, N Gribble, P Robinson, A Lloyd, S White</div><div class="gs_gray">ATN Assessment Conference 2009: Assessment in Different Dimensions, 66<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13626852934223829418" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:WbkHhVStYXYC" class="gsc_a_at">Ocular implants</a><div class="gs_gray">AW Lloyd, S Sandeman, RGA Faragher, SP Denyer</div><div class="gs_gray">Encyclopedia of biomaterials and biomedical engineering, 1098-1104<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3530603247536998938,9053065915192317296" class="gsc_a_ac gs_ibl">4</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="AO9ywNcAAAAJ:WbkHhVStYXYC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:uWQEDVKXjbEC" class="gsc_a_at">Differential cell adhesion to phosphorylcholine polymers with varying cationic charge</a><div class="gs_gray">SF Long, AL Lewis, GW Hanlon, AW Lloyd</div><div class="gs_gray">European Cells and Materials 2 (1), 50-51<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2597690908325920443" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:pyW8ca7W8N0C" class="gsc_a_at">Human telomerase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 3 (11), 523-523<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10285557545519616432" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:B3FOqHPlNUQC" class="gsc_a_at">Lead identification to candidate selection</a><div class="gs_gray">WH Streng, AW Lloyd</div><div class="gs_gray">Pharmaceutical Science &amp; Technology Today 1 (6), 231-233<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18427054666905259627" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:dshw04ExmUIC" class="gsc_a_at">Reduced bacterial adhesion to novel biomimetic soft contact lenses</a><div class="gs_gray">CS Andrews, SP Denyer, GW Hanlon, AW Lloyd, B Hall, RWJ Bowers</div><div class="gs_gray">Investigative Ophthalmology and Visual Science 38 (4), 2401-2401<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=240890301552022372" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:SP6oXDckpogC" class="gsc_a_at">Reduced tear film spoilation of novel soft contact lens materials</a><div class="gs_gray">CS Andrews, AW Lloyd, DP Sharma, B Hall, GW Hanlon, SP Denyer</div><div class="gs_gray">Vision Research 36, 325-325<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1758766877309560952" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:sSrBHYA8nusC" class="gsc_a_at">Chiral inversion of the enantiomers of 2-phenylpropionic acid by Cordyceps militaris</a><div class="gs_gray">YF Hung, GW Hanlon, AW Lloyd, MJ Thomason, W Rhys-Williams</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 47 (12), 1097<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=772373195490902089" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ShjGdcaqzI0C" class="gsc_a_at">Biomaterial with functionalised surfaces</a><div class="gs_gray">AW Lloyd, GWJ Olivier, G Standen, M Santin, ST Meikle</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10952545049551759914" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:olpn-zPbct0C" class="gsc_a_at">Enhancing first-year undergraduate chemistry teaching and learning quality-application of intranet-based resources</a><div class="gs_gray">M Sosabowski, K Herson, A Lloyd</div><div class="gs_gray">South African Journal of Chemistry 51 (4), 193-199<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17826021725239946944" class="gsc_a_ac gs_ibl">3</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="AO9ywNcAAAAJ:olpn-zPbct0C">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:tS2w5q8j5-wC" class="gsc_a_at">Overcoming Resistance to Networked Learning and Teaching Modalities—A Longitudinal Comparison of Changing Teaching Staff Attitudes Towards Learning Technologies</a><div class="gs_gray">K Herson, AW Lloyd, R Stanier, MH Sosabowski</div><div class="gs_gray">Pharmacy Education 3 (3)<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14690930886811090127" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:KxtntwgDAa4C" class="gsc_a_at">Middle molecule adsorption from ultrafiltrate for use in intensive care medicine</a><div class="gs_gray">KA Scorgie, JG Davies, GJ Phillips, AW Lloyd, MK Street, C Kingswood, ...</div><div class="gs_gray">Asaio Journal 47 (2), 157<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17662847248984525108" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:1qzjygNMrQYC" class="gsc_a_at">Biomaterials—where are we going?</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Pharmaceutical Science &amp; Technology Today 1 (9), 363-364<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10221563536126970265" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:tH6gc1N1XXoC" class="gsc_a_at">H-3 receptor agonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (6), 295-295<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9487922897326408922" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:iyewoVqAXLQC" class="gsc_a_at">The synthesis and evaluation of diacylglycerol analogues as potential second-messenger antagonists</a><div class="gs_gray">JC Briggs, AP Dawson, I Gibson, AH Haines, J Hook, A Lloyd, S Meiners, ...</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 2 (2), 127-130<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15732979580828823759" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">A comparative study of the cryopreservation of human erythrocytes, ghosts and liposomes</a><div class="gs_gray">CA BREARLEY, AW LLOYD, NA HODGES, CJ OLLIFF</div><div class="gs_gray">Biochemical Society Transactions 16 (3), 354-354<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2511391944605915643" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:mel-f30kHHgC" class="gsc_a_at">In vitro and in vivo characterisation of a multiple tyrosine kinase inhibitor drug eluting bead</a><div class="gs_gray">A Hagan, W Macfarlane, A Lloyd, G Phillips, R Holden, Z Bascal, ...</div><div class="gs_gray">Journal of Vascular and Interventional Radiology 3 (27), S84<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11317278247456881266" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Controlled delivery of doxorubicin and rapamycin from embolization microspheres to treat hepatocellular carcinoma: 28</a><div class="gs_gray">R Forster, C Bowyer, A Lewis, W Macfarlane, G Phillips, A Lloyd</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 60<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13450940782699936879" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ehoypfNsBj8C" class="gsc_a_at">The cytotoxic assessment of carbon adsorbents</a><div class="gs_gray">LM Barnes, MC Murphy, M Melillo, GJ Phillips, JG Davies, AW Lloyd, ...</div><div class="gs_gray">Transactions-7th World Biomaterials Congress<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6793749881291128982" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:b0M2c_1WBrUC" class="gsc_a_at">Furanone-based antibacterial coatings: Surface science</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">Materials Today 7 (7-8), 23<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17477528907872902723" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Tear evaporation in contact lens wear</a><div class="gs_gray">AW Lloyd, N Mahalingham, M Guillon</div><div class="gs_gray">Investigative Ophthalmology &amp; Visual Science 45 (13), 3890-3890<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7463383044928761025" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:wbdj-CoPYUoC" class="gsc_a_at">Effects of oxygen plasma treatment on the surface wettability and dissolution of furosemide compacts</a><div class="gs_gray">A Naseem, CJ Olliff, LG Martini, AW Lloyd</div><div class="gs_gray">Journal of pharmacy and pharmacology 55 (11), 1473-1478<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13084469574829557405" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:X4-KO54GjGYC" class="gsc_a_at">Ophthalmology: Biomaterials</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Elsevier<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4498644965017889589" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:P5F9QuxV20EC" class="gsc_a_at">The interaction of bisphosphonate-coated hydroxyapatite and osteoblasts</a><div class="gs_gray">A Ganguli, AW Lloyd, ST Meikle, MH Grant</div><div class="gs_gray">Society for Biomaterials<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14704822618392257127" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:xtRiw3GOFMkC" class="gsc_a_at">PharmacogenomicsQualitative Gene Profiling Using Differential Analysis of Transcripts With Alternative Splicing</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">Drug discovery today 5 (9), 429-430<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1001339186999765886" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:08ZZubdj9fEC" class="gsc_a_at">Marine natural products as therapeutic agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (1), 34-34<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13758018054121626047" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:8AbLer7MMksC" class="gsc_a_at">Modulation of multidrug resistance by taxinine derivatives</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (6), 289-290<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2437217823001139276" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:o9ULDYDKYbIC" class="gsc_a_at">Inhibition of ligand-gated cation channels by the quaternary ethylbromide derivative of tamoxifen.</a><div class="gs_gray">MC Allen, PA Gale, C Newland, AC Hunter, AW Lloyd, SP Hardy</div><div class="gs_gray">Journal of Physiology, 515-515<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7594829108583199014" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:MLfJN-KU85MC" class="gsc_a_at">Anti-MRSA agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 3 (10), 480-480<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17459688220454859975,14836384246904086103" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Tiz5es2fbqcC" class="gsc_a_at">Can we relieve the drug development bottleneck?</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Pharmaceutical Science &amp; Technology Today 1 (2), 45-46<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6050600295604067087" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:eflP2zaiRacC" class="gsc_a_at">New delivery systems for macromolecules</a><div class="gs_gray">A Hilleiy, A Lloyd</div><div class="gs_gray">Drug Discovery Today 2 (10), 402-404<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6506992528033845103" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Optimization of the Chiral Inversion of 2‐Phenylpropionic Acid by <i>Verticillium lecanii</i></a><div class="gs_gray">MJ THOMASON, W RHYS‐WILLIAMS, AW LLOYD, GW HANLON</div><div class="gs_gray">Journal of pharmacy and pharmacology 49 (3), 263-269<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10895748065441595855" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:tOudhMTPpwUC" class="gsc_a_at">Selective cleavage of ketals and acetals</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 219<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13155946048044063191" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:LPZeul_q3PIC" class="gsc_a_at">Glycocalyx Adsorption Enhances Biocompatibility of Poly (Methyl Methacrylate)</a><div class="gs_gray">RGA Faragher, S Nagri, S Dropcova, SV Mikhalovsky, AW Lloyd, ...</div><div class="gs_gray">Fundamentals of Adsorption, 285-292<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3125366215357538910" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:738O_yMBCRsC" class="gsc_a_at">Application of molecular modelling to the design of azo compounds for use in colon specific drug delivery</a><div class="gs_gray">J Bragger, AW Lloyd, D Barlow, GP Martin, C Marriott, SF Bloomfeld, ...</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 45 (2), 1126<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10462585378549695306" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ifOnle78iJkC" class="gsc_a_at">Towards Hypoxia-responsive Drug-eluting Embolization Beads</a><div class="gs_gray">K Ashrafi, CL Heaysman, GJ Phillips, AW Lloyd, AL Lewis</div><div class="gs_gray">International journal of pharmaceutics 524 (1-2), 226-237<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9522324616589876964" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:IyxfXMz2bNAC" class="gsc_a_at">Oral drug delivery</a><div class="gs_gray">AM Hillery, AW Lloyd, J Swarbrick</div><div class="gs_gray">Drug Delivery and Targeting, 147-183<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10322957285172699861" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:KWzIFqRkAKkC" class="gsc_a_at">Current Trends in Biomaterial Coatings</a><div class="gs_gray">SV MIKHALOVSKY, M SANTIN, LI MIKHALOVSKA, AW LLOYD, ...</div><div class="gs_gray">Nanostructured Materials and Coatings for Biomedical and Sensor Applications&nbsp;…<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14623906793292562297" class="gsc_a_ac gs_ibl">1</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="AO9ywNcAAAAJ:KWzIFqRkAKkC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:5icHVeHT4IsC" class="gsc_a_at">Nanocomposites based on multicomponent polymer matrix and artificial diamond nanofiller</a><div class="gs_gray">LV Karabanova, VA Bershtein, AW Lloyd, SV Mikhalovsky</div><div class="gs_gray">Proceedings of 15th European conference on composite materials, Venice&nbsp;…<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16500415050992283239" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:jtI9f0ekYq0C" class="gsc_a_at">Delivery of drug combinations</a><div class="gs_gray">AL Lewis, REJ Forster, MV Gonzalez-Fajardo, Y Tang, AW LLoyd, ...</div><div class="gs_gray">US Patent App. 12/672,031<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12200010435010921882" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:q3oQSFYPqjQC" class="gsc_a_at">Method for the stabilisation of purified p-glycoprotein</a><div class="gs_gray">A Heikal, M Allen, R Callaghan, AW Lloyd</div><div class="gs_gray">US Patent App. 12/676,288<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11256037935347351447" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:UxriW0iASnsC" class="gsc_a_at">Biomaterial with functionalised surfaces</a><div class="gs_gray">AW Lloyd, GWJ Olivier, G Standen, M Santin, ST Meikle</div><div class="gs_gray">US Patent App. 12/517,705<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10056280864888112731" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Reinforced polymers for connective tissue: Tissue engineering</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">Materials Today 7 (5), 19<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1287823805845638284" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:__bU50VfleQC" class="gsc_a_at">Alternatives to PVC: Medical materials</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">Materials Today 7 (2), 19<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1370177946016805475" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:7Frjd3zlGBUC" class="gsc_a_at">A novel carbon device for the treatment of sepsis: 44</a><div class="gs_gray">S Sandeman, C Howell, G Phillips, A Lloyd, S Mikhalovsky, J Davies, ...</div><div class="gs_gray">Therapeutic Apheresis and Dialysis 7 (5)<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5574455479112394023" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:XiSMed-E-HIC" class="gsc_a_at">Soft tissue replacement</a><div class="gs_gray">M Santin, L Ambrosio, AW Lloyd, SP Denyer</div><div class="gs_gray">Integrated Biomaterials Science, 425-458<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5858823606438765875" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:uoRD4RTSUPoC" class="gsc_a_at">Experimental flow studies in glaucoma filtration implant development</a><div class="gs_gray">KS Lim, BDS Allan, PT Khaw, S Willis, AW Lloyd, A Muir, P Gard, ...</div><div class="gs_gray">The British Journal of Ophthalmology 85, 1231-1236<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16882586930957111345" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:MhiOAD_qIWkC" class="gsc_a_at">Therapeutic agents for the treatment of Alzheimer's disease</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 5 (10), 479-479<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12510811778152158542" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:XiVPGOgt02cC" class="gsc_a_at">Aza-podophyllotoxin as potent cytotoxic agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (6), 260-260<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16270382700112943470" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">Monitor: progress and profiles</a><div class="gs_gray">AW Lloyd, AC Hunter</div><div class="gs_gray">Pharmaceutical science &amp; technology today 3 (4), 146-150<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8198542416954421618,190094907978669601" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:vbGhcppDl1QC" class="gsc_a_at">Molecules cyclooxygenase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 5 (3), 121-122<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3528676376520163557" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:EkHepimYqZsC" class="gsc_a_at">Using the new learning technologies: integrating learning technologies into professional development programmes</a><div class="gs_gray">K Herson, M Sosabowski, A Lloyd</div><div class="gs_gray">New directions in professional higher education, 83-89<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2848857703700119274" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:5ugPr518TE4C" class="gsc_a_at">Do biomaterial surfaces influence the conformation of adsorbed fibrinogen and the subsequent adhesion of bacteria?</a><div class="gs_gray">J Martin, RGA Faragher, S Cederholm-Williams, G Hanlon, A Lloyd</div><div class="gs_gray">Artificial Organs 23 (7)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14144403440726316023" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:HE397vMXCloC" class="gsc_a_at">alpha (4) beta (1) integrin inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (4), 186-186<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18186445324248308507" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">Novel antibacterial agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (4), 186-186<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12593512128960395583,3803562406245476138" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:F9fV5C73w3QC" class="gsc_a_at">The synthesis and evaluation of poly (carboxybetaines) as novel anti-adherent biomaterials</a><div class="gs_gray">S Meikle, AC Hunter, C Steward, E Ampilozous, A Lloyd</div><div class="gs_gray">Artificial Organs 23 (7), 635<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8684835598504377730" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">Growth hormone secretagogue</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (10), 480-481<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5117612311883582741" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:9NZAP19TdFAC" class="gsc_a_at">Factor Xa inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (4), 190-190<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=160681637559085526" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:VjBpw8Hezy4C" class="gsc_a_at">Endothelin receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (12), 554-554<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14926691601974773405" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:7Hz3ACDFbsoC" class="gsc_a_at">Human neutrophil elastase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 2 (4), 162-162<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11801544860975790312" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">The effect of tear film conditioning on bacterial adhesion to contact lens materials</a><div class="gs_gray">CS Andrews, AW Lloyd, GW Hanlon, SP Denyer, B Hall</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 49, 11-11<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7579449908250892032" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:eJXPG6dFmWUC" class="gsc_a_at">Solid-phase synthesis of 2′ and 3′-aminonucleoside triphosphates</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 219-220<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5185222131523444523" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:3htObqc8RwsC" class="gsc_a_at">Synthesis of L-(+)-ergothioneine</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (2), 84-84<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8108898848400701252" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:D_sINldO8mEC" class="gsc_a_at">Bacterial cleavage of novel azo polymer cross-linking compounds to free amines</a><div class="gs_gray">J Bragger, AW Lloyd, C Marriott, SF Bloomfeld, GP Martin, J Phillips</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 47 (12), 1122-1122<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6377160917520657730" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Analysis of the surface tension and zeta potential of modified small particulates in relation to extent of phagocytosis</a><div class="gs_gray">CA Holden, CJ Olliff, AW Lloyd, F Paul</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 44, 1065-1065<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4327429016707344459" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:BzfGm06jWhQC" class="gsc_a_at">The synthesis and comparison of modified betaines as cryoprotective agents</a><div class="gs_gray">AW Lloyd, KJ Rutt, CJ Olliff</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 42 (S1), 75P-75P<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11298925774259192361" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:j7XjBeKFbTsC" class="gsc_a_at">Vandetanib-eluting radiopaque beads for chemoembolization: physicochemical evaluation and biological activity of vandetanib in hypoxia.</a><div class="gs_gray">AE Hagan, SA Znati, R Carter, A Westhorpe, WM Macfarlane, GJ Phillips, ...</div><div class="gs_gray">Anti-cancer Drugs<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:pxXbYLTb8EgC" class="gsc_a_at">Delivery of drug combinations</a><div class="gs_gray">AL Lewis, REJ Forster, MV Gonzalez-Fajardo, Y Tang, AW Lloyd, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:NU-BerS4NX4C" class="gsc_a_at">Polymers and microspheres</a><div class="gs_gray">CL Heaysman, A Lloyd, GJ Phillips, AL Lewis</div><div class="gs_gray">US Patent App. 15/756,689<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:_AeoHAGD03cC" class="gsc_a_at">Drug carriers comprising amphilphilic block copolymers</a><div class="gs_gray">AL Lewis, SP Armes, AW Lloyd, P Jonathan</div><div class="gs_gray">US Patent 9,765,213<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:3MwzVuqRcA0C" class="gsc_a_at">Nanocomposites Based on Thermosetting Polyurethane Matrix and Chemically Modified Multiwalled Carbon Nanotubes</a><div class="gs_gray">LV Karabanova, RL Whitby, VA Bershtein, PN Yakushev, AW Lloyd, ...</div><div class="gs_gray">International Conference on Nanotechnology and Nanomaterials, 115-148<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:NnTm98qLMbgC" class="gsc_a_at">Drug Targeting Systems: Fundamentals and Applications to Parenteral Drug Delivery</a><div class="gs_gray">AM Hillery, AW Lloyd, J Swarbrick</div><div class="gs_gray">Drug Delivery and Targeting, 121-146<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:PkcyUWeTMh0C" class="gsc_a_at">Biomimetic developments to improve the OOKP</a><div class="gs_gray">V Avadhanam, C Liu, A Lloyd, S Sanderman</div><div class="gs_gray">Acta Ophthalmologica 91<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:F1b5ZUV5XREC" class="gsc_a_at">Is a synthetic lamina the ultimate goal for osteo‐odonto‐keratoprosthesis (OOKP) surgery? Options for the edentulous patient who require OOKP surgery</a><div class="gs_gray">A LLOYD, V AVADHANAM, S SANDEMAN, C LIU</div><div class="gs_gray">Acta Ophthalmologica 90<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:2v_ZtQDX9iAC" class="gsc_a_at">Biomaterial with functionalised surfaces</a><div class="gs_gray">AW Lloyd, GWJ Olivier, G Standen, M Santin, ST Meikle</div><div class="gs_gray">US Patent App. 12/862,233<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:CNPyR2KL9-0C" class="gsc_a_at">Targeting HIF-1 and mTOR expression in hypoxic and normoxic liver cancer cells; towards optimal combination therapy for DEB-TACE</a><div class="gs_gray">C Bowyer, R Forster, A Lewis, A Lloyd, W Macfarlane, G Phillips</div><div class="gs_gray">Cancer and metabolism: pathways to the future<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ye4kPcJQO24C" class="gsc_a_at">New biomaterials for keratoprostheses</a><div class="gs_gray">AW LLOYD, BJ TIGHE, V FRANKLIN, R HUHTINEN, S SANDEMANN, ...</div><div class="gs_gray">Acta Ophthalmologica 88<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:AHdEip9mkN0C" class="gsc_a_at">BPC 2008: Pharmacy in the 21st century</a><div class="gs_gray">A Lloyd, C Hughes</div><div class="gs_gray">Pharmaceutical Journal 280 (7497), 440-441<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:_9Xh93LWpsYC" class="gsc_a_at">Guest editorial: selected papers from the 21st European conference on Biomaterials, Brighton, UK, 9-13 September 2007</a><div class="gs_gray">A Lloyd, M Santin, G Phillips</div><div class="gs_gray">Journal of Materials Science 19 (4), 1451-1452<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:lgwcVrK6X84C" class="gsc_a_at">Gradient composites and semi-interpenetrating polymer. Networks based on polyurethane and poly (2-hydroxyethyl Methacrylate) for biomedical applications</a><div class="gs_gray">L Karabanova, LM Sergeeva, ED Lutsyk, AV Svyatyna, G Seytre, ...</div><div class="gs_gray">European Polymer Congress, EPF<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:bCjgOgSFrM0C" class="gsc_a_at">Mesporous carbons</a><div class="gs_gray">Y Gogotsi, G Yushin, SV Mikhalovsky, AW Lloyd, GJ Phillips</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:j7_hQOaDUrUC" class="gsc_a_at">Gradient polyurethane/PHEMA composites and semi-interpenetrating polymer networks for biomedical application</a><div class="gs_gray">L Karabanova, LM Sergeeva, OL Brovko, AW Lloyd, SV Mikhalovsky, ...</div><div class="gs_gray">International Conference Materials 2007<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:5MTHONV0fEkC" class="gsc_a_at">Selected papers from the 10th International Conference on Polymers in Medicine &amp; Surgery, Cambridge UK, 2004</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE 17 (12), 1191-1192<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:TesyEGJKHF4C" class="gsc_a_at">Towards a synthetic OOKP support frame: 4213</a><div class="gs_gray">M BELIN, B ZERBE, R VIITALA, V FRANKLIN, B TIGHE, C LIU, A LLOYD</div><div class="gs_gray">Acta Ophthalmologica Scandinavica 84<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:GFxP56DSvIMC" class="gsc_a_at">A novel carbon-containing device for adsorption of cytokines in the treatment of sepsis</a><div class="gs_gray">CA Howell, SR Sandeman, GJ Phillips, AW Lloyd, SV Mikhalovsky, ...</div><div class="gs_gray">Carbon 2006: The International Carbon Conference<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:rzmi0EmCOGEC" class="gsc_a_at">Treatment of sepsis</a><div class="gs_gray">SR Tennison, GJ Phillips, SV Mikhalovsky, AW Lloyd, JM Courtney</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:uLbwQdceFCQC" class="gsc_a_at">Disinfection of biofilms using Toluidine Blue O and Red Light</a><div class="gs_gray">TB Gallagher, GW Hanlon, AW Lloyd, JY Maillard</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 57, S106-S106<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:N4u4nq0IxgcC" class="gsc_a_at">A novel system for combined plasmapheresis and adsorption in the treatment of sepsis, based on activated carbon</a><div class="gs_gray">HLH Owen, JJ Rouse, JM Courtney, EM Smith, CA Howell, SR Sandeman, ...</div><div class="gs_gray">The British Carbon Group Workshop-Carbon Materials: Science and Art<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:artPoR2Yc-kC" class="gsc_a_at">Los criogeles y su caracterización mediante microscopia electrónica de barrido ambiental</a><div class="gs_gray">AW Lloyd, SV Mikhalovsky, MRA de Armas, D Gómez, I Galaev, F Plieva</div><div class="gs_gray">Revista de plásticos modernos: Ciencia y tecnología de polímeros, 368-375<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:uVUOdF_882EC" class="gsc_a_at">Interpenetrating networks provide a new insight OPHTHALMIC BIOMATERIALS</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">MATERIALS TODAY 7 (11), 28-28<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:2l5NCbZemmgC" class="gsc_a_at">Biomimetic self-assembling polymeric nanosystems for drug delivery</a><div class="gs_gray">J Salvage, G Hanlon, A Lloyd, IY Ma, SP Armes, NC Billingham, A Lewis</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 56 (S1), 115-116<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:69ZgNCALVd0C" class="gsc_a_at">Towards a novel carbon device for the treatment of sepsis</a><div class="gs_gray">SR Sandeman, CA Howell, GJ Phillips, AW Lloyd, SV Mikhalovsky, ...</div><div class="gs_gray">The American Carbon Society, A13-A14<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:XeErXHja3Z8C" class="gsc_a_at">Real-time qPCR</a><div class="gs_gray">AM van der Valk, DN Howbrook, M OShaunessey, S Baker, D Sarker, ...</div><div class="gs_gray">Abgene Insights 16, 16-17<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:U5uP8zs9lfgC" class="gsc_a_at">A novel carbon device for the treatment of sepsis</a><div class="gs_gray">CA Howell, SR Sandeman, GJ Phillips, AW Lloyd, SV Mikhalovsky, ...</div><div class="gs_gray">Transactions-7th World Biomaterials Congress, 559<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:4E1Y8I9HL1wC" class="gsc_a_at">The role of surface chemistry and porosity on the adsorption of inflammatory mediators</a><div class="gs_gray">MC Murphy, GJ Phillips, AW Lloyd, JG Davies, SV Mikhalovsky</div><div class="gs_gray">Transactions-7th World Biomaterials Congress, 1793<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:eI34FqJmdUoC" class="gsc_a_at">Development of an activated carbon-based system for combined plasmapheresis and adsorption in the treatment of sepsis</a><div class="gs_gray">HLH Owen, JM Courtney, EM Smith, CA Howell, SR Sandeman, ...</div><div class="gs_gray">31st Annual Congress of the European Society for Artificial Organs (ESAO)<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:u3T1itk59dMC" class="gsc_a_at">Osteoblast response to a novel titanium biomimetic treatment</a><div class="gs_gray">E Sandrini, M Santin, C Giordano, R Chiesa, AW Lloyd, SP Denyer, ...</div><div class="gs_gray">Society for Biomaterials 29th annual meeting, 455-455<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:EBV337fEn3EC" class="gsc_a_at">Assessment of MG63 response to a novel titanium biomimetic treatment</a><div class="gs_gray">E Sandrini, M Santin, C Giordano, R Chiesa, AW Lloyd, S Denyer, ...</div><div class="gs_gray">18th European Conference on Biomaterials, P015-P015<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:EaFouW7jFu4C" class="gsc_a_at">The use of carbon-and resin-based adsorbents to complement therapeutic filtration systems</a><div class="gs_gray">G Phillips, K Scorgie, M Murphy, A Lloyd, G Davies, C Olliff, S Mikhalovsky</div><div class="gs_gray">Perfusion 17, 77-78<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:PQEM9vzQD9gC" class="gsc_a_at">Osteoblast growth and bacterial adhesion on bisphosphonate coated hydroxyapatite</a><div class="gs_gray">A Ganguli, AW Lloyd, C Steward, SH Butler, G Philips, ST Meikle, ...</div><div class="gs_gray">Institute of Physics and Engineering in Medicine 27th Annual Day Conference&nbsp;…<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:WA5NYHcadZ8C" class="gsc_a_at">CURRENT TRENDS 1N B1OMATER1AL COAT1NGS</a><div class="gs_gray">AW LLOYD, SP DENVER</div><div class="gs_gray">Nanostructured Materials and Coatings for Biomedical and Sensor Applications, 15<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:GHsHDPAyICYC" class="gsc_a_at">Drug Delivery and Targeting: Introduction to advanced drug delivery and targeting</a><div class="gs_gray">AM Hillery, AW Lloyd, J Swarbrick</div><div class="gs_gray">Taylor &amp; Francis<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:xa5BkEQK8BgC" class="gsc_a_at">Insulin kinase receptor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (12), 572-572<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:mVC4hKzE2FoC" class="gsc_a_at">P38 kinase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (12), 570-571<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:rbm3iO8VlycC" class="gsc_a_at">Progress. Process analysis.</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">Pharmaceutical science &amp; technology today 3 (12), 431-434<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:jE2MZjpN3IcC" class="gsc_a_at">Emerging molecular targets Gp130-mediated signalling as a therapeutic target</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (12), 571-572<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:LdasjJ6CEcoC" class="gsc_a_at">Inhibition of galactose-binding proteins</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (12), 572-573<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:1yQoGdGgb4wC" class="gsc_a_at">Combinatorial chemistry-Melatoninergic ligands</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (12), 572-572<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:sgsej9ZJWHMC" class="gsc_a_at">alpha (1A)-adrenoceptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (11), 528-529<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:2KloaMYe4IUC" class="gsc_a_at">5-HT1D-receptor antagonists for the treatment of migraine</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (11), 530-530<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:DQNrXyjhriIC" class="gsc_a_at">Monitor: PROGRESS</a><div class="gs_gray">AW Lloyd, A Christy</div><div class="gs_gray">Pharmaceutical science &amp; technology today 3 (10), 365-366<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:WAzi4Gm8nLoC" class="gsc_a_at">Phosphodiesterase 5 inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (10), 479-479<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:oi2SiIJ9l4AC" class="gsc_a_at">Non-amidine-containing 1, 2-dibenzamidobenzene inhibitors of human factor Xa</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (10), 478-478<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:6_hjMsCP8ZoC" class="gsc_a_at">Combinatorial chemistry-Neuropeptide Y-receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (10), 480-480<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:LPtt_HFRSbwC" class="gsc_a_at">Novel potassium channel openers</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (10), 478-478<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:e_rmSamDkqQC" class="gsc_a_at">Endothelin A-receptor antagonists</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (10), 479-480<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:eMMeJKvmdy0C" class="gsc_a_at">Potent beta (3)-adrenoceptor agonists as potential anti-obesity drugs</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (10), 477-478<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:iKswqCX-FLkC" class="gsc_a_at">Non-peptide receptor agonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (9), 428-428<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:HJSXoJQnj-YC" class="gsc_a_at">Molecules-Novel HIV protease inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (9), 427-427<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">High-throughput SNP scoring</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (9), 430-430<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:zCSUwVk65WsC" class="gsc_a_at">Selective dopamine D4-receptor ligands</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (9), 431-431<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:HtEfBTGE9r8C" class="gsc_a_at">CCR5 antagonists as anti-HIV agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (9), 428-429<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:0izLItjtcgwC" class="gsc_a_at">Dopamine-receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (9), 428-428<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:vDijr-p_gm4C" class="gsc_a_at">Combinatorial chemistry-Matrix metalloprotease inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (9), 431-431<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:eq2jaN3J8jMC" class="gsc_a_at">Neuropeptide YY5-receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (9), 427-428<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:q-HalDI95KYC" class="gsc_a_at">Potent subtype-selective c-Src inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (8), 376-376<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">Injectable COX-2 inhibitor: parecoxib sodium</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 5 (8), 374-374<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:XoXfffV-tXoC" class="gsc_a_at">Human serotonin N-acetyltransferase</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (8), 376-376<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:SpbeaW3--B0C" class="gsc_a_at">Dual cytokine regulators</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (8), 373-374<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:p__nRnzSRKYC" class="gsc_a_at">Selective alpha (1)-adrenoceptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (8), 375-375<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:uWiczbcajpAC" class="gsc_a_at">Quinonic derivatives active against Toxoplasma gondii</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (8), 373-373<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:VLnqNzywnoUC" class="gsc_a_at">Rationally designed anticancer drug</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (8), 375-375<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:PR6Y55bgFSsC" class="gsc_a_at">Ocular angiostatic agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (8), 374-375<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:_B80troHkn4C" class="gsc_a_at">Inhibitors of bacterial signal transduction kinase</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (8), 376-376<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:J4E9jCG1tHUC" class="gsc_a_at">Human cytosolic phospholipase A (2) inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (7), 301-302<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:LXmCCkuhhTsC" class="gsc_a_at">Highly potent in vivo AMPA-receptor antagonists</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (7), 302-302<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">Lipoprotein-associated phospholipase A (2) inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (7), 301-301<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:U4n9YNQMCAIC" class="gsc_a_at">Combinatorial chemistry-Subsite preferences in aminopeptidase A</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (6), 261-261<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:9pM33mqn1YgC" class="gsc_a_at">Hypoxia-sensitive antitumour compounds</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (6), 260-261<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:evX43VCCuoAC" class="gsc_a_at">Molecules-Novel, selective and potent 5-HT7-receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (6), 259-259<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:zzCxg_vo7cAC" class="gsc_a_at">Molecules-Neuropeptide YY5-receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (5), 210-210<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:TeJ9juy8vcMC" class="gsc_a_at">Orally active GPIIb/IIIa-receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (4), 164-165<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:wUn16MOA3RoC" class="gsc_a_at">Integrin alpha (v) beta (3)-receptor antagonists</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (4), 165-166<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:pS0ncopqnHgC" class="gsc_a_at">Opioid receptor-like antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (4), 164-164<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">AAPS triggers quest for magic bullet</a><div class="gs_gray">AW Lloyd, AC Hunter, A Smith</div><div class="gs_gray">Pharmaceutical Science &amp; Technology Today 3 (4), 118-120<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:DkZNVXde3BIC" class="gsc_a_at">Antitumour therapy: Patent focus</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (3), 123-123<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:U_HPUtbDl20C" class="gsc_a_at">Library of serine and cysteine protease inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (3), 123-124<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:PyEswDtIyv0C" class="gsc_a_at">Varicella-zoster virus inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (3), 123-123<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">Adenosine A (3)-receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (3), 122-123<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:tYavs44e6CUC" class="gsc_a_at">Potent anti-MRS agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (3), 122-122<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">Patent focus on drug delivery: June-November 1999</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Expert Opinion on Therapeutic Patents 10 (3), 273-277<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Combinatorial chemistry-Separation of serine proteases</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (3), 123-123<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ce2CqMG-AY4C" class="gsc_a_at">Molecules subtype-selective NMDA-receptor ligands</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (2), 85-85<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:kVjdVfd2voEC" class="gsc_a_at">Combinatorial chemistry-Melanocortin-1 receptor agonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (2), 86-87<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:bKqednn6t2AC" class="gsc_a_at">Purine nucleoside phosphorylase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (2), 85-86<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:0N-VGjzr574C" class="gsc_a_at">Nitric oxide synthase inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (2), 86-86<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:gsN89kCJA0AC" class="gsc_a_at">Enkephalin mimetics</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (2), 87-87<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:EYYDruWGBe4C" class="gsc_a_at">Tyrosine kinase ZBP-70 inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (2), 86-86<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:v_xunPV0uK0C" class="gsc_a_at">Human 5-HT1D-receptor agonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (1), 33-33<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:JTqpx9DYBaYC" class="gsc_a_at">Erm methyltransferase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (1), 34-35<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:NyGDZy8z5eUC" class="gsc_a_at">High-throughput screening-Rapid fluorescent-based reporter-gene assays for HTS of platinum-based cytotoxic agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (1), 35-35<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:cWzG1nlazyYC" class="gsc_a_at">Human dopamine d4-receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (1), 33-33<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:edDO8Oi4QzsC" class="gsc_a_at">Hurdles to successful implementation of module-and course-based newsgroups</a><div class="gs_gray">M Sosabowski, K Herson, A Lloyd, G Olivier</div><div class="gs_gray">Framework for Optimising C&amp;IT Uptake and Support Online<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">Cysteinyl LT1-receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (1), 34-34<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Combinatorial chemistry-Fourier-transform screening</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 5 (1), 34-34<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Domain-driven adsorption of fibrin (ogen) onto silk-fibroin-based biomaterials</a><div class="gs_gray">M Santin, A Motta, M Migliaresi, AW Lloyd, SP Denyer</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 52 (9; SUPP/1), 305-305<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:UmS_249rOGwC" class="gsc_a_at">Combinatorial chemistry-Synthesis of beta-lactams</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (12), 570-571<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:-mN3Mh-tlDkC" class="gsc_a_at">Emerging molecular targets-Apoptotic protease activating factor-1</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (12), 570-570<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:fbc8zXXH2BUC" class="gsc_a_at">Book review: Biopharmaceutical Drug Design and Development, edited by Susanna Wu-Pong and Yongyut Rojanasakul</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Pharmaceutical Science &amp; Technology Today 2 (12), 470<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:DUooU5lO8OsC" class="gsc_a_at">Molecules-Histamine H-3-receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (12), 568-568<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:86PQX7AUzd4C" class="gsc_a_at">NR1/2B NMDA-receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (12), 569-569<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Cvh0bltMcLgC" class="gsc_a_at">Metalloproteinase inhibitors in snakebite envenomations</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (11), 532-532<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:UuEBAcK4md4C" class="gsc_a_at">Orally active arginine vasopressin-receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (11), 530-531<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:CdxZDUztZiMC" class="gsc_a_at">Combinatorial chemistry-NMR-based screening</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (11), 532-532<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:jgBuDB5drN8C" class="gsc_a_at">Influenza sialidase inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (11), 531-531<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:GtLg2Ama23sC" class="gsc_a_at">Neuropeptide YY1-receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (11), 531-531<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:w1MjKQ0l0TYC" class="gsc_a_at">Combinatorial chemistry-Novel antitumour agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (10), 481-482<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:OBSaB-F7qqsC" class="gsc_a_at">Leukocyte elastase and macrophage metalloelastase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (10), 481-481<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:48xauSegjOkC" class="gsc_a_at">High-affinity retinoic acid receptor-antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (10), 481-481<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:rmuvC79q63oC" class="gsc_a_at">Purine CDK inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (10), 482-482<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:epqYDVWIO7EC" class="gsc_a_at">Hexose-related imidazolidinones</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (10), 480-480<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:hEXC_dOfxuUC" class="gsc_a_at">Novel MMP inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (8), 385-385<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Xz60mAmATU4C" class="gsc_a_at">Antitumour activity of thioester derivatives of leinamycin.</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug discovery today 4 (8), 384-386<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:BJbdYPG6LGMC" class="gsc_a_at">Nonsteroidal androgen receptor agonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (8), 386-386<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:_axFR9aDTf0C" class="gsc_a_at">IL-6 secretion inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (8), 385-385<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:tzM49s52ZIMC" class="gsc_a_at">Novel screening methodology</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (8), 386-387<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:LjlpjdlvIbIC" class="gsc_a_at">Thrombin inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (8), 384-385<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:dFKc6_kCK1wC" class="gsc_a_at">The Synthesis and Evaluation of Poly (Carboxybetaines) as Novel Anti-Adherent Biomaterials</a><div class="gs_gray">A Hunter, E Ampatizdou, S Meikle, C Steward, A Lloyd</div><div class="gs_gray">Artificial Organs 23 (7)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:MGPUR4WVBMEC" class="gsc_a_at">Novel anti-osteoporosis agent</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (7), 335-335<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:NDuN12AVoxsC" class="gsc_a_at">Selective cyclooxygenase-2 inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (7), 334-335<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:KaMxkj08jr0C" class="gsc_a_at">3-(Piperazinylpropyl) indoles: h5-HT1D receptor agonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (7), 333-333<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Br1UauaknNIC" class="gsc_a_at">(3-substituted benzyl) thiazolidine-2, 4-diones: new antihyperglycaemic agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (7), 335-335<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:nZcligLrVowC" class="gsc_a_at">Acrylate Modified p (HEMA) Polymers for Use as Keratoprosthetic Skirt Materials</a><div class="gs_gray">S Sandeman, R Faragher, C Liu, M Allen, A Lloyd</div><div class="gs_gray">Artificial Organs 23 (7)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:FAceZFleit8C" class="gsc_a_at">High-affinity GABA (A) receptor ligands</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (7), 334-334<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:-FonjvnnhkoC" class="gsc_a_at">Novel inhibitors of carboxypeptidase G (2): applications in ADEPT therapy</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (7), 334-334<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">Novel non-xanthine adenosine A (1) receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (7), 333-334<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Adsorbent Regeneration of Ultrafiltrate for Use in Intensive Care Medicine</a><div class="gs_gray">K Scorgie, J Davies, S Mikhalovsky, C Olliff, A Lloyd, M Street, ...</div><div class="gs_gray">Artificial Organs 23 (7)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:O0nohqN1r9EC" class="gsc_a_at">Dual inhibitors of phosphodiesterase type 4 and matrix metalloproteinases</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (6), 290-291<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:FiytvqdAVhgC" class="gsc_a_at">Controlling gastric emptying</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (6), 290-290<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:BwyfMAYsbu0C" class="gsc_a_at">Tetrahydrobenzindoles as selective 5-HT7 receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (6), 290-290<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Novel structural classes of p38 kinase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (6), 289-289<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Ade32sEp0pkC" class="gsc_a_at">Novel antithrombotic therapy</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (5), 239-239<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:yxmsSjX2EkcC" class="gsc_a_at">Novel nonsteroidal androgen-receptor agonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (5), 238-239<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:OcBU2YAGkTUC" class="gsc_a_at">Corneal endothelial cell damage from glaucoma drainage device materials</a><div class="gs_gray">K Lim, RG Faragher, PT Khaw, A Mulr, AW Lloyd, B Allan</div><div class="gs_gray">INVEST OPHTH VIS SCI 40 (4), S628-S628<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:RJNGbXJAtMsC" class="gsc_a_at">Endothelin ETB receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (3), 139-140<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:yCjxvIMm6_oC" class="gsc_a_at">Cholesterol and plasma lipid modifying agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (3), 139-139<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:HeT0ZceujKMC" class="gsc_a_at">Monitor.</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug discovery today 4 (3), 139-140<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:WZBGuue-350C" class="gsc_a_at">4, 5-Diarylimidazoles as selective cyclooxygenase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (3), 140-140<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:yB1At4FlUx8C" class="gsc_a_at">Osteoclast V-ATPase inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (3), 140-140<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:z_wVstp3MssC" class="gsc_a_at">Dual D-2-receptor and beta (2)-adrenoceptor agonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (3), 140-140<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">UREMIC TOXIN ADSORPTION BY NOVEL SYNTHETIC PYROLYSED CARBON ADSORBENTS</a><div class="gs_gray">KA Scorgie, SL Moore, JG Davies, S Mikhalovsky, CJ Olliff, AW Lloyd, ...</div><div class="gs_gray">Asaio Journal 45 (2), 176<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:N5tVd3kTz84C" class="gsc_a_at">Monitor.</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug discovery today 4 (3), 139-140<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ZysSsiWj_g4C" class="gsc_a_at">Substituted pyrazoles as novel D-4 receptor ligands</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (2), 93-93<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ufKn5pxu7C0C" class="gsc_a_at">MEK inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (2), 93-94<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:as0KMg8qHbkC" class="gsc_a_at">p38 kinase inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (2), 94-94<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:qwy9JoKyICEC" class="gsc_a_at">LHRH receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (2), 94-94<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Hck25ST_3aIC" class="gsc_a_at">Novel fluoroquinolone antibiotics</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (2), 93-93<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:X9ykpCP0fEIC" class="gsc_a_at">An investigation into bacterial agglutination in the presence of fibrinogen</a><div class="gs_gray">J Martin, S Cederholm-Williams, RGA Faragher, GW Hanlon, AW Lloyd</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 51, 37-37<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:EPG8bYD4jVwC" class="gsc_a_at">An evaluation of the biocompatibility of novel phosphorylcholine using HL60 cell line</a><div class="gs_gray">JE Hughes, RGA Faragher, B Hall, GW Hanlon, AW Lloyd</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 51, 162-162<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:CB2v5VPnA5kC" class="gsc_a_at">The synthesis and evaluation of novel anti-bioadherent materials: poly (carboxybetaines)</a><div class="gs_gray">AC Hunter, ST Meikle, E Ampatzidou, C Steward, AW Lloyd</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 51, 318-318<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:NXb4pA-qfm4C" class="gsc_a_at">Phosphodiesterase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (1), 40-41<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">The formation of a particulate delivery system using MG145-LCP</a><div class="gs_gray">K Fletcher, AT Florence, PR Gard, AM Hillery, AW Lloyd, I Toth</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 51, 7-7<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:KUbvn5osdkgC" class="gsc_a_at">N-type calcium channel blockers</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (1), 39-39<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">Natural antitumour agent</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 4 (1), 39-39<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">A comparison of the use of bioluminescent ATP assay and image analysis for the measurement of bacterial adhesion to soft contact lenses</a><div class="gs_gray">CS Andrews, AW Lloyd, GW Hanlon, SP Denyer, B Hall</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 51, 217-217<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:kzcrU_BdoSEC" class="gsc_a_at">AAPS meeting builds bridges for the new millennium</a><div class="gs_gray">D Tranter, A Lloyd</div><div class="gs_gray">Pharmaceutical Science &amp; Technology Today 1 (2), 3-4<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ujxm2eEBZHIC" class="gsc_a_at">Thromboxane receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (12), 562-562<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:-7ulzOJl1JYC" class="gsc_a_at">Corticotrophin-releasing factor 1 receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (12), 562-562<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:uDGL6kOW6j0C" class="gsc_a_at">Nonpeptide integrin antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (12), 561-562<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:i2xiXl-TujoC" class="gsc_a_at">Cyclic urea protease inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (12), 561-561<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:4MWp96NkSFoC" class="gsc_a_at">Potent inhibitor of factor Xa</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (12), 562-562<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ybfzIt2tCtgC" class="gsc_a_at">Sensor arrays</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (11), 524-524<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Ic1VZgkJnDsC" class="gsc_a_at">Kinase inhibitor libraries</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (11), 524-524<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:8Xgff_V0N9gC" class="gsc_a_at">Glycogen phosphorylase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (11), 523-524<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:jSAVyFp_754C" class="gsc_a_at">Antitumour agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (11), 522-522<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:HhcuHIWmDEUC" class="gsc_a_at">Anti-Helicobacter pylori agent</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (11), 524-524<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:4fGpz3EwCPoC" class="gsc_a_at">Thrombin inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (11), 522-523<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:35r97b3x0nAC" class="gsc_a_at">In Vitro Biocompatibility Testing of Intraocular Biomaterials</a><div class="gs_gray">SP Denyer, S Dropcova, RGA Faragher, PR Gard, GW Hanlon, AW Lloyd, ...</div><div class="gs_gray">Ocular Radiation Risk Assessment in Populations Exposed to Environmental&nbsp;…<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:G36d5HCDkJYC" class="gsc_a_at">Substrate-based protein tyrosine kinase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (10), 482-482<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">Glucose uptake inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (10), 481-482<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:anf4URPfarAC" class="gsc_a_at">Arginine vasopressin antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (10), 481-481<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Natural products glabracins A and B</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (10), 481-481<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:TiIbgCYny7sC" class="gsc_a_at">Serine proteinase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (9), 423-423<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:u0Mu_IsstPMC" class="gsc_a_at">Cyclic MMP inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (9), 423-423<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ziOE8S1-AIUC" class="gsc_a_at">Sugar library templates</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (9), 425-425<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:pAkWuXOU-OoC" class="gsc_a_at">Potent dual 5-lipoxygenase inhibitor and PAF receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (9), 424-424<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:L1USKYWJimsC" class="gsc_a_at">High-affinity neurokinin receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (9), 424-424<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:_OXeSy2IsFwC" class="gsc_a_at">Combinatorial chemistry-Gene expression inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (9), 425-425<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">Monitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 3 (9), 423-425<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:_Ybze24A_UAC" class="gsc_a_at">Potent thromboxane receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (9), 425-425<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:JQOojiI6XY0C" class="gsc_a_at">Novel oral hypoglycaemic agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (9), 424-424<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:vofGIMt6cyEC" class="gsc_a_at">Matrix metalloproteinase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (8), 386-387<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:GtqhT-R7ZnwC" class="gsc_a_at">Bone resorption inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (8), 387-387<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:bXQfdp6S9ecC" class="gsc_a_at">Macrophage metalloelastase inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (8), 387-387<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:IsPWOBWtZBwC" class="gsc_a_at">HIV-1 non-nucleoside reverse transcriptase inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (8), 387-387<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:rHJHxKgnXwkC" class="gsc_a_at">Cholesterol biosynthesis control</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (8), 389-389<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:WC9gN4BGCRcC" class="gsc_a_at">Squalene epoxidase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (8), 390-390<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Library of adrenergic agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (8), 388-388<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">Thrombin inhibitors with nonbasic P1 side-chains</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (8), 388-388<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:9vf0nzSNQJEC" class="gsc_a_at">Squalene synthase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (8), 389-390<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:htyGaKyDgHMC" class="gsc_a_at">beta-lactamase inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (7), 350-350<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:43bX7VzcjpAC" class="gsc_a_at">Selective inhibitor of human inducible nitric oxide synthase</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (7), 350-350<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:QD3KBmkZPeQC" class="gsc_a_at">Dopamine D4 receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (7), 351-351<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:jL-93Qbq4QoC" class="gsc_a_at">Bioactive acetogenins</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (7), 351-351<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Ehil0879vHcC" class="gsc_a_at">Potent, selective alpha (1b)-adrenergic receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (7), 350-351<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:umqufdRvDiIC" class="gsc_a_at">Nonpeptidic RANTES antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (7), 351-351<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:a9-T7VOCCH8C" class="gsc_a_at">Natural antitumour agent</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (7), 351-351<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:yZoBfgUKqwcC" class="gsc_a_at">Proteasome inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (6), 295-296<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:65Yg0jNCQDAC" class="gsc_a_at">HIV immune evasion</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (6), 298-298<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:jU7OWUQzBzMC" class="gsc_a_at">5-HT7 receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (6), 296-296<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:nRpfm8aw39MC" class="gsc_a_at">Combinatorial chemistry</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (6), 296-296<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:dBIO0h50nwkC" class="gsc_a_at">Potent inhibitor of NF-kappa B-and AP-1-mediated gene expression</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (6), 296-296<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:p2g8aNsByqUC" class="gsc_a_at">Orally active thrombin inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (6), 295-295<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:cdwqcPQS8ssC" class="gsc_a_at">Endothelin antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (4), 191-191<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:F2UWTTQJPOcC" class="gsc_a_at">Mel (1b) melatonin receptor ligand</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (4), 190-190<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">Influenza A antiviral</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (4), 189-189<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:6yz0xqPARnAC" class="gsc_a_at">5-HT1B receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (4), 189-189<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:4X0JR2_MtJMC" class="gsc_a_at">Library analysis by mass spectrometry</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (4), 191-192<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:yFnVuubrUp4C" class="gsc_a_at">Adenosine deaminase inhibitor library</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (4), 192-192<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:9c2xU6iGI7YC" class="gsc_a_at">Oral antitumour agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (4), 189-189<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:tKAzc9rXhukC" class="gsc_a_at">Bis-quinolinium cyclophanes</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (4), 190-190<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">Farnesyltransferase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (4), 190-191<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:aIdbFUkbNIkC" class="gsc_a_at">Neuropeptide Y antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (3), 141-141<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:rTD5ala9j4wC" class="gsc_a_at">Novel thrombin inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 3 (3), 141-141<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:M7yex6snE4oC" class="gsc_a_at">Enhancing Learning and Teaching Quality–Adoption of Intranet Learning Resources</a><div class="gs_gray">M Sosabowski, K Herson, A Lloyd</div><div class="gs_gray">7th International Chemistry Conference in Africa/34th Convention of the&nbsp;…<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:hkOj_22Ku90C" class="gsc_a_at">Emerging molecular targets</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">Drug Discovery Today 11 (3), 525<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:wkm4DBaukwsC" class="gsc_a_at">Antibacterial solution libraries</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (12), 556-556<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:v6i8RKmR8ToC" class="gsc_a_at">Collagenase inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (12), 554-554<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:BrOSOlqYqPUC" class="gsc_a_at">Novel immunostimulants</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (12), 555-556<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">New natural products</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (12), 555-555<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:foquWX3nUaYC" class="gsc_a_at">Combinatorial chemistry-Hydroxystilbene kinase inhibitor library</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (12), 556-556<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:fEOibwPWpKIC" class="gsc_a_at">CCKB/gastrin antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (12), 555-555<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:t6usbXjVLHcC" class="gsc_a_at">Leukotriene B-4 receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (12), 554-555<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:I9gX6wnfuA8C" class="gsc_a_at">Anti-MRSA agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (10), 446-446<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:3NQIlFlcGxIC" class="gsc_a_at">A linker for amidines</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (10), 447-447<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:OP4eGU-M3BUC" class="gsc_a_at">Water-soluble synthetic receptors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (10), 447-447<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:YohjEiUPhakC" class="gsc_a_at">Newly discovered human 15-lipoxygenase</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (10), 448-448<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:HqhvjgTjE9cC" class="gsc_a_at">COX-2 inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (9), 393-393<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:WMtz-WDmgKQC" class="gsc_a_at">Selective D-4 receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (9), 392-392<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:FiDNX6EVdGUC" class="gsc_a_at">New class of anticonvulsant agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (9), 393-393<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">Pyridone-based peptidomimetic ICE inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (9), 391-391<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:sJsF-0ZLhtgC" class="gsc_a_at">Immunosuppressive cyclic nonapeptide</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (9), 391-391<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:4vMrXwiscB8C" class="gsc_a_at">ETA-selective endothelin antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (9), 392-393<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">Novel antiparasitic binaphthalene</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (9), 391-392<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">Novel antihypertensive agent</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (9), 393-393<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:5bg8sr1QxYwC" class="gsc_a_at">Thiophene-2-alkylsulphonamides as 5-LO inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (8), 352-352<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:HGTzPopzzJcC" class="gsc_a_at">Human T cell kv1. 3 potassium channel blocker</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (8), 352-353<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:6bLC7aUMtPcC" class="gsc_a_at">Fertilization inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (8), 353-353<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:hsZV8lGYWTMC" class="gsc_a_at">Trisubstituted ureas as ACAT inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (8), 352-352<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:a3BOlSfXSfwC" class="gsc_a_at">Heterocyclic fused pyridazinones as PDE 4 inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (8), 351-352<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:sNmaIFBj_lkC" class="gsc_a_at">Oestrogen receptor modulator</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (8), 351-351<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">Angiotensin II (AT (1)) antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (8), 352-352<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">Novel pyranoxanthones</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 2 (7), 301-306<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:It0W0vAlS5QC" class="gsc_a_at">Muscarinic analgesics</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (6), 247-248<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:mKu_rENv82IC" class="gsc_a_at">Orally active CCKB antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (6), 247-247<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ILKRHgRFtOwC" class="gsc_a_at">Nicotinic acetylcholine receptor ligand</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (6), 247-247<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:BPS1z4jHU5cC" class="gsc_a_at">5-HT3 receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (5), 206-206<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:mWEH9CqjF64C" class="gsc_a_at">Cytotoxic nortopsentin D analogue</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (5), 206-206<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:eAUscmXIlQ8C" class="gsc_a_at">NK1 antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (4), 162-162<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:NZNkWSpQBv0C" class="gsc_a_at">CNS stimulants</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (4), 162-162<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:-DxkuPiZhfEC" class="gsc_a_at">Systemic lupus erythematosus inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (4), 163-163<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:sA9dB-pw3HoC" class="gsc_a_at">Selective SKCa blockers</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (4), 161-161<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:QyXJ3EUuO1IC" class="gsc_a_at">Bradykinin antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (4), 163-163<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:DBa1UEJaJKAC" class="gsc_a_at">Novel 3'-trifluoromethyl taxoids</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (4), 161-161<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Hepatitis B antiviral</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (4), 161-161<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">Senescence in ocular keratocytes</a><div class="gs_gray">R Faragher, M Allen, A Lloyd, S Sandeman, S Dropcova</div><div class="gs_gray">Investigative Ophthalmology &amp; Visual Science 38 (4), 5397-5397<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:SdhP9T11ey4C" class="gsc_a_at">Histochemical characterisation of the corneal cells in keratoconus</a><div class="gs_gray">S Dropcova, V Vesela, RGA Faragher, AW Lloyd, M Filipec</div><div class="gs_gray">INVESTIGATIVE OPHTHALMOLOGY &amp; VISUAL SCIENCE 38 (4), 5075-5075<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:MAUkC_7iAq8C" class="gsc_a_at">Selective COX-2 inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (3), 122-122<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:1yWc8FF-_SYC" class="gsc_a_at">Differential metabolism of gamma-linolenic acid and the components of evening primrose oil by MCF7 human breast epithelial cells in vitro</a><div class="gs_gray">NM Tyers, AW Lloyd, SL James, PR Gard</div><div class="gs_gray">BRITISH JOURNAL OF PHARMACOLOGY 120, P321-P321<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:buQ7SEKw-1sC" class="gsc_a_at">AMPA receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (3), 122-123<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:nVrZBo8bIpAC" class="gsc_a_at">Novel cytostatic rearranged cholestane glycoside</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (3), 123-123<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:LhH-TYMQEocC" class="gsc_a_at">Ras farnesyl protein transferase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (3), 123-123<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:hCrLmN-GePgC" class="gsc_a_at">Heterocyclic ureas as hypocholesterolaemic agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (3), 123-123<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:kzcSZmkxUKAC" class="gsc_a_at">Bicyclic HIV protease inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (2), 79-79<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:RoXSNcbkSzsC" class="gsc_a_at">Cytotoxic natural products</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (2), 79-79<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Mojj43d5GZwC" class="gsc_a_at">CCKB antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 2 (2), 79-80<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:raTqNPD5sRQC" class="gsc_a_at">Biomimetic coatings to reduce fibrin blockage of glaucoma filtration implants</a><div class="gs_gray">B Allan, RWJ Bowers, S Dropcova, SP Denyer, RGA Faragher, PR Gard, ...</div><div class="gs_gray">Investigative Ophthalmology and Visual Science 38 (4), 1252-1252<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:OR75R8vi5nAC" class="gsc_a_at">Novel method of a stable liposome preparation</a><div class="gs_gray">MI Hingle, AW Lloyd, J Maas, CJ Olliff, P Taylor</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 49, 144-144<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ODE9OILHJdcC" class="gsc_a_at">An investigation into the use of PVC/poloxamer blends as potential biocompatible materials</a><div class="gs_gray">RS Kerai, S Reed, AW Lloyd, CJ Olliff</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 49, 121-121<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:IRz6iEL74y4C" class="gsc_a_at">Arends-Scholte, AW, see Te Wierik, GHP 157, 181 Arias-Blanco, MJ, see Moyano, JR 157, 239 Arneric, SP, see Qiu, Y. 157, 43 Axelsson, A., see Andersson, M. 157, 199</a><div class="gs_gray">JL Bragger, AW Lloyd, SH Soozandehfar, SF Bloomfield, C Marriott, ...</div><div class="gs_gray">International Journal of Pharmaceutics 157, 245-246<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:g3aElNc5_aQC" class="gsc_a_at">Abnormal metabolism of gamma-linolenic acid by human breast epithelial cells</a><div class="gs_gray">NM Tyers, AW Lloyd, SL James, PR Gard</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 49, 2-2<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:u_mOZUIutIEC" class="gsc_a_at">Novel thrombin inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (12), 533-533<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:SWgZeABleR0C" class="gsc_a_at">3', 5'-Diamino-3', 5'-dideoxynucleosides</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (12), 535-535<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:B2rIPIGFPLEC" class="gsc_a_at">Leukotriene B-4 receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (12), 534-534<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:zGdJYJv2LkUC" class="gsc_a_at">Novel HIV-1 protease inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (12), 533-534<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:prdVHNxh-e8C" class="gsc_a_at">New spiro-and tricyclic pyridazino [4, 5c] pyridazinones</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (12), 535-535<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ubry08Y2EpUC" class="gsc_a_at">Novel adenosine A (1) antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (12), 533-533<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Cannabinoid receptor ligands</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (12), 534-534<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">Phosphonobutoxypurine antivirals</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (12), 533-533<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:IUKN3-7HHlwC" class="gsc_a_at">Cyanomethylation of diarylethenes</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (12), 535-535<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">alpha (2)-Andrenoceptor agonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (12), 534-534<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:LI9QrySNdTsC" class="gsc_a_at">High fluidity supports for solid phase synthesis</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (12), 536-536<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:hMsQuOkrut0C" class="gsc_a_at">Secretory PLA (2) inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (12), 534-534<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Stereocontrolled synthesis of beta-2'-deoxyribonucleosides</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (12), 535-535<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:DGzKIA18-3YC" class="gsc_a_at">Novel satiety agent</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (11), 489-489<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:SGW5VrABaM0C" class="gsc_a_at">Asymmetric synthesis of halenaquinone and halenaquinol</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (11), 491-491<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:3bvyWxjaHKcC" class="gsc_a_at">Orally active angiotensin II receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (11), 489-489<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:kw52XkFRtyQC" class="gsc_a_at">Enantiocontrolled synthesis of (+)-boronolide</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (11), 491-491<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:1taIhTC69MYC" class="gsc_a_at">Sialyl Lewis X mimetics</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (11), 490-490<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:XvxMoLDsR5gC" class="gsc_a_at">Synthesis of benzo [c] phenanthridine alkaloids</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (11), 491-491<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">Novel NK1 antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (11), 490-490<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:URolC5Kub84C" class="gsc_a_at">Novel antiproliferative retinoids</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (11), 489-490<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:PELIpwtuRlgC" class="gsc_a_at">Brasiliquinones AC</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (11), 490-490<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:VN7nJs4JPk0C" class="gsc_a_at">Histological and immunocytochemical analysis of fuchs' endothelial dystrophy</a><div class="gs_gray">S Dropcova, AW Lloyd, RGA Faragher, AJ Bron, V Vesela, M Filipec</div><div class="gs_gray">VISION RESEARCH 36, 111-111<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:x2hKVfJWtf0C" class="gsc_a_at">Dopamine receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (9), 399-399<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:tgTmbKTkO1IC" class="gsc_a_at">Fibrinogen receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (9), 399-399<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:IHkkN1K1AlAC" class="gsc_a_at">Diastereoselective synthesis of octahydroacridines</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (9), 400-400<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Dem6FJhTUoYC" class="gsc_a_at">NK3 receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (9), 398-399<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:WC23djZS0W4C" class="gsc_a_at">Inhibitors of dipeptidyl peptidase IV</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (9), 398-398<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:gVv57TyPmFsC" class="gsc_a_at">Novel organic nitrate esters</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (9), 398-398<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:u-coK7KVo8oC" class="gsc_a_at">4-Azidobenzyloxycarbamate prodrugs</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (9), 400-400<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:_5tno0g5mFcC" class="gsc_a_at">Endothelin converting enzyme inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (9), 399-399<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Synthesis of pyrazolo [3, 4-b] pyridines</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (9), 400-400<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:5rMqqAh47xYC" class="gsc_a_at">Synthesis of 2-aminochromones and 2-aminopyrones</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (8), 354-354<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:1xBWf43XMUgC" class="gsc_a_at">Novel carbacephems</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (8), 354-354<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:IT1MJ6E3JesC" class="gsc_a_at">Potent HIV and HBV inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (8), 353-353<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:CCeGMaHljPEC" class="gsc_a_at">Catalytic asymmetric allylation of aldehydes</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (8), 354-354<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:AXkvAH5U_nMC" class="gsc_a_at">Cholecystokinin-B/gastrin-receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (8), 353-353<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:8xutWZnSdmoC" class="gsc_a_at">Nitric oxide synthase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (8), 352-352<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:LO7wyVUgiFcC" class="gsc_a_at">Tachykinin antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (8), 352-352<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">Adhesion molecule expression inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (8), 353-353<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ipzZ9siozwsC" class="gsc_a_at">Asymmetric synthesis of the dihydroisocoumarin moiety of Al-77-B</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (8), 354-354<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ZuybSZzF8UAC" class="gsc_a_at">Selective dopamine D-4 antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (8), 353-353<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:HKviVsUxM5wC" class="gsc_a_at">5-HT4 receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (7), 305-306<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:1EqfMoDn7-AC" class="gsc_a_at">1-aryl-2-(tosylamino)-1H-imidazoles</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (7), 307-307<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:rFyVMFCKTwsC" class="gsc_a_at">Synthesis of nucleosides from furan</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (7), 307-307<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:qPeb-qHga9sC" class="gsc_a_at">Novel syntheses of tetrahydropyrroloquinolines</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (7), 307-307<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:QUX0mv85b1cC" class="gsc_a_at">Novel prodrugs of d4T</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (7), 306-306<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:1DsIQWDZLl8C" class="gsc_a_at">M (3) agonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (7), 305-305<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:SjuI4pbJlxcC" class="gsc_a_at">C1r serine protease inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (7), 305-305<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:0CzhzZyukY4C" class="gsc_a_at">Dual AChE and MAO inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (7), 305-305<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:fFSKOagxvKUC" class="gsc_a_at">alpha-L-iduronidase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (7), 306-306<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">Imidazoline 1 receptor-specific agent</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (7), 306-306<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:WqliGbK-hY8C" class="gsc_a_at">H-3 receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (7), 306-306<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:urP0JZOBBUsC" class="gsc_a_at">HIV-1 protease inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (6), 261-261<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:eFf2swCANGcC" class="gsc_a_at">Phosphotyrosine isosteres</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (6), 263-263<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:sJK75vZXtG0C" class="gsc_a_at">Novel antidepressant agent</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (6), 261-261<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:DIubQTN3OvUC" class="gsc_a_at">Selective PGD (2) receptor agonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (6), 262-262<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:oYLFIHfuHKwC" class="gsc_a_at">Kinetic resolution using nonenzymatic acylating agents</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (6), 263-264<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:9LpHyFPp1DQC" class="gsc_a_at">Metabotropic glutamate receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (6), 262-262<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:17ZO-CJnx_8C" class="gsc_a_at">Synthesis of pyridine derivatives</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (6), 263-263<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Tfl4UtY-dJUC" class="gsc_a_at">Orally active squalene synthase inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (6), 261-261<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:inmFHauC9wsC" class="gsc_a_at">Novel fungal phospholipase D inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (6), 262-262<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:YPNY0knpFBYC" class="gsc_a_at">Dopamine D-3 receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (6), 261-261<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:rpSJNIKeXWsC" class="gsc_a_at">AMPA receptor inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 218<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:4oJvMfeQlr8C" class="gsc_a_at">Enantioselective total synthesis of (+)-duocarmycin A</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 219<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:NXYAu82O0W8C" class="gsc_a_at">Selective estrogen receptor modulators</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 217<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:oAywNP-vUhwC" class="gsc_a_at">Synthesis of benzo [c]-thiophenes</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 220<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:zdX0sdgBH_kC" class="gsc_a_at">Penochalasins</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 217<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:wuD5JclIwkYC" class="gsc_a_at">Piezoelectric IgM immunosensor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (5), 223-223<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:CYCckWUYoCcC" class="gsc_a_at">Balanced angiotensin II receptor antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 218<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:SnGPuo6Feq8C" class="gsc_a_at">Synthesis of pyrrolo [2, 1 c][1, 4] benzodiazepie antibiotics</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 219<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:An6A6Jpfc1oC" class="gsc_a_at">Preparation of secondary amines</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 220<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:1lhNe0rCu4AC" class="gsc_a_at">Total synthesis of antifungal FR-900848</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 219<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:DJbcl8HfkQkC" class="gsc_a_at">Nonpeptide somatostatin ligand</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 218<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:PVjk1bu6vJQC" class="gsc_a_at">Synthesis of fused 1, 2, 4-thiadiazoles</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 220<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">Neuronal calcium channel blocker</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (5), 218<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:nOiSByfp82kC" class="gsc_a_at">Synthesis of L-734,217</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (4), 172-172<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:oynPyU19kbsC" class="gsc_a_at">HIV-1 integrase inhibitor</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (4), 170-170<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:XtJa11BXPS4C" class="gsc_a_at">3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (4), 169-170<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:j8pvxH-kN2QC" class="gsc_a_at">5-alkylresorcinols</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (4), 169-169<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:NtGNdKbuCngC" class="gsc_a_at">NK1 receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (4), 169-169<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:W5xh706n7nkC" class="gsc_a_at">alpha (2)-adrenoceptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (4), 170-170<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:vD2iS2Kej30C" class="gsc_a_at">Topoisomerase II inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (3), 122-122<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Nufq_to8ts0C" class="gsc_a_at">Indirect enzymic phosphorylation</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (3), 124-124<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ojlX30-wUrgC" class="gsc_a_at">Novel cell adhesion inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (3), 123-123<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:S2WlVNSe3u4C" class="gsc_a_at">Novel optically pure triols</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (3), 124-124<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:wGzT3bKASkAC" class="gsc_a_at">Corticotropin-releasing factor and Alzheimer's disease</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (3), 127-127<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:T8_be82Iz5gC" class="gsc_a_at">Novel non-indole 5-HT1D agonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (3), 123-123<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Gpwnp1kGG20C" class="gsc_a_at">Antiviral evaluation of thionucleosides</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (3), 123-123<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:nWoA1JPTheMC" class="gsc_a_at">Reduction of lactones</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (3), 124-124<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:SIv7DqKytYAC" class="gsc_a_at">Novel oxytocin antagonist</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (3), 122-122<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">Asymmetric synthesis of pyrrolidinoisoquinoline derivatives</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (3), 125-125<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">HIV-1 reverse transcriptase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (3), 122-122<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:cF7EPgIk0B4C" class="gsc_a_at">Chiral boron enolates</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (2), 84-84<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:wBLCggQE-ToC" class="gsc_a_at">Dopamine D-3-antagonists and partial agonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (2), 82-82<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:K4-iKlO5MD4C" class="gsc_a_at">Selective 5-HT4 receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (2), 83-83<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:3vbIHxFL9FgC" class="gsc_a_at">N-acetyl-alpha-D-mannosamine 1-phosphate analogues</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (2), 83-83<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Nw_I7GeUguwC" class="gsc_a_at">Stereochemical modulation of pharmacological activity</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (2), 83-83<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:XUvXOeBm_78C" class="gsc_a_at">alpha-alkylated gamma, delta-unsaturated amino acids</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (2), 83-83<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:J-pR_7NvFogC" class="gsc_a_at">Michael addition of alpha-sulphinyl and alpha-sulphonyl carbanions</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (2), 84-84<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:xii_ZKWM4-0C" class="gsc_a_at">Protein kinase C inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (1), 40-40<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:a2necdfpwlEC" class="gsc_a_at">Antioxidant hypocholesterolemic agents</a><div class="gs_gray">JP Gotteland</div><div class="gs_gray">Drug Discovery Today 6 (1), 261-262<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:BW2nPTmhBn4C" class="gsc_a_at">Synthesis of pyrrolo [2, 3-d] pyrimidines</a><div class="gs_gray">EC Taylor, HH Patel, JG Jun</div><div class="gs_gray">Drug Discovery Today 2 (1), 83-84<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:ghEM2AJqZyQC" class="gsc_a_at">Orally active squalene synthase inhibitor</a><div class="gs_gray">Y Iwasawa</div><div class="gs_gray">Drug Discovery Today 6 (1), 261<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:hSRAE-fF4OAC" class="gsc_a_at">Total synthesis of piperidine alkaloid (+)-himbacine</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (1), 41-41<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:QsaTk4IG4EwC" class="gsc_a_at">The use of confocal laser microscopy to study the cellular uptake of colloidal carriers</a><div class="gs_gray">AM Hillary, R Faragher, CJ Olliff, AW Lloyd</div><div class="gs_gray">European Journal of Pharmaceutical Sciences, S196<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:TlpoogIpr_IC" class="gsc_a_at">Monitor: molecules, synthesis and profiles</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 11 (1), 489-490<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:kF1pexMAQbMC" class="gsc_a_at">Nitric oxide sensor</a><div class="gs_gray">E Leung</div><div class="gs_gray">Drug Discovery Today 4 (1), 172<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:v1_lew4L6wgC" class="gsc_a_at">Solid-phase synthesis in the development of small-molecule libraries</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (1), 42-43<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:lvd772isFD0C" class="gsc_a_at">Investigation into the location of chiral inversion enzymes in Cordyceps Militaris</a><div class="gs_gray">YF Hung, MJ Thomason, W Rhys-Williams, AW Lloyd, GW Hanlon</div><div class="gs_gray">European Journal of Pharmaceutical Sciences, S125<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:yqoGN6RLRZoC" class="gsc_a_at">Angiotensin II receptor antagonists</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (1), 39-40<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:yMeIxYmEMEAC" class="gsc_a_at">Mechanistic studies on the chiral inversion of 2-phenylpropionic acid by verticillium lecanii</a><div class="gs_gray">MJ Thomason, YF Hung, W Rhys-Williams, GW Harion, AW Lloyd</div><div class="gs_gray">European Journal of Pharmaceutical Sciences, S125<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:4hFrxpcac9AC" class="gsc_a_at">Acyl-CoA: Cholesterol acyl transferase inhibitors</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">DRUG DISCOVERY TODAY 1 (1), 40-40<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">Chiral Europe'95</a><div class="gs_gray">W Rhys-Williams, A Lloyd</div><div class="gs_gray">Drug Discovery Today 1 (1), 7<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors</a><div class="gs_gray">N Turabi</div><div class="gs_gray">Drug Discovery Today 4 (1), 169-170<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Case histories in drug discovery</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Drug Discovery Today 3 (1), 90-91<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:otzGkya1bYkC" class="gsc_a_at">Microbial chiral inversion of non-steroidal anti-inflammatory drugs by Verticillium Lecanii under non-growing conditions</a><div class="gs_gray">MJ Thomason, W Rhys-Williams, GW Hanlon, AW Lloyd, AJ Hutt</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 47 (12), 1059-1059<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:mlAyqtXpCwEC" class="gsc_a_at">Senescence of corneal endothelial cells</a><div class="gs_gray">S Dropcova, SP Denyer, PR Gard, GW Hanlon, AW Lloyd, ...</div><div class="gs_gray">Vision Research, S159<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:NJ774b8OgUMC" class="gsc_a_at">Investigations into the mechanism of biological azo reduction</a><div class="gs_gray">SH Soozandehfar, AW Lloyd, NA Hodges, GP Martin</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 47 (12), 1120-1120<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">Voltage control of molecular diffusion through novel liquid crystalline membranes</a><div class="gs_gray">S Roberts, DM Ryder, CJ Olliff, AW Lloyd</div><div class="gs_gray">Proceedings of 8th International Symposium on Electrets (ISE 8), 973-978<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:PVgj2kMGcgYC" class="gsc_a_at">The neutrophil: edited by JS Abramson and JG Wheeler, Oxford University Press, 1993.£ 25.00/$43.00 (xxv+ 306 pages) ISBN 0 19 963373 8</a><div class="gs_gray">A Lloyd</div><div class="gs_gray">Immunology Today 15 (3), 142<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:KNjnJ3z-R6IC" class="gsc_a_at">A novel technique for the visualization of multilamellar liposomes under scanning electron microscopy using ruthenium tetroxide fixation</a><div class="gs_gray">DJ Gwilliam, GJ Phillips, CJ Olliff, AJ Bone, AW Lloyd</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 46 (2), 1071<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Bacterial cleavage of azo compounds to free amines</a><div class="gs_gray">J Bragger, AW Lloyd, C Marriott, SF Bloomfeld, GP Martin, J Phillips</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 45 (2), 1134<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:owLR8QvbtFgC" class="gsc_a_at">The effects of various hydrocolloid ostomy wafers on the bacteriological flora of the skin</a><div class="gs_gray">Z Parveen, GW Hanlon, AW Lloyd, D Hollingsbee</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 44, 1095-1095<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:kWvqk_afx_IC" class="gsc_a_at">The Effect of Cryoprotective Additives on the Zeta Potential of Liposomes</a><div class="gs_gray">AW Lloyd, KJ Rutt, CJ Olliff</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 42 (Supplement_1), 143P-143P<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=AO9ywNcAAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=AO9ywNcAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">The synthesis and evaluation of potential cryoprotectants.</a><div class="gs_gray">AW Lloyd</div><div class="gs_gray">Brighton Polytechnic<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–598</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>